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Service providers in the south 
east of Ireland agreed to pilot 
the National Drug Treatment 
Reporting System (NDTRS) 
exit form in 2007. The south 
east includes counties Carlow, 
Kilkenny, Waterford, Wexford 
and South Tipperary. The exit 
form records all treatment 
interventions received by a client 
during a treatment episode, along 
with details of their treatment 
outcome at the time of discharge 
or transfer to another service. 
Drug treatment options include 
psycho-social interventions 
(brief intervention, counselling, 
group therapy, family therapy, 
psychotherapy, complementary 
therapy, and/or life-skills training) and medical interventions (detoxifi cation, methadone reduction, 
substitution programmes and psychiatric treatment). Service providers in the south east recorded 
exit details for all clients discharged from their service in 2007. 
The NDTRS collects data on episodes of treatment, rather than the number of individual people 
treated each year. This means that individuals may appear more than once if they attended and 
were discharged from more than one treatment service in a calendar year. 
The main fi ndings from the pilot project are:
In 2007, 1,630 cases exited treatment in the south east. Complete data were provided for  ■
1,586 cases. Table 1 shows the number of these cases by the year they entered treatment. 
Analysis of treatment outcomes 
in the south east
Table 1 Number of cases exiting treatment in 2007, 
 by year entered treatment for this episode
Year entered treatment n %
2003 3 0.2
2004 6 0.4
2005 24 1.5
2006 146 9.2
2007 1,407 88.7
Total 1,586 100.0
Of the 1,586 cases exiting treatment, 1,319 (83.2%) lived in the south east, 262 (16.5%) lived  ■
in another area of Ireland, and 5 (0.3%) lived outside of Ireland.
Treatment for problem alcohol and drug use in Ireland is provided by statutory and non- ■
statutory services, including residential centres, community-based addiction services, general 
practices and prison services. Of the 1,586 cases exiting treatment in 2007, 1,101 (69.4%) 
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Treatment outcomes (continued) 
received treatment in an outpatient setting, 
and 485 (30.6%) in an inpatient setting.  
Low-threshold services (outpatient setting) 
provided treatment to 77 (4.9%) cases. 
General practitioners and prisons were not 
invited to participate in the pilot study as 
their data are not collected through the HSE 
South Drug Co-ordination Unit.
The majority (69.3%) of clients exiting  ■
treatment in 2007 were male. 
The main problem substances reported  ■
by clients on entry to treatment were 
alcohol (69.2%), cannabis (11.8%), opiates 
(8.3%), and cocaine (5.8%). Other cases 
reported ecstasy, other stimulants (such 
as amphetamines), volatile inhalants, or 
benzodiazepines as their main problem drug. 
Just over two-fi fths (41.4%) reported  ■
problem use of more than one substance 
(polysubstance use) on entry into treatment. 
One-fi fth (20%) of referrals to treatment  ■
were made by hospitals/medical agencies, 
and 12.7% by the courts, probation services 
or police. 
Of the 106 clients who reported that  they  ■
had injected at some point in their life, 
over half (54.7%) reported that had shared 
injecting equipment. 
Treatment interventions can be classifi ed  ■
as psycho-social or medical. Clients may 
receive a number of interventions during 
a treatment episode. Of these, service 
providers identifi ed one as the main 
treatment intervention when completing 
the exit form. Psycho-social interventions 
accounted for 94.5% of the main treatment 
interventions provided, while the remaining 
5.5% were medical interventions. 
The main psycho-social interventions  ■
provided were counselling (46.9%), 
medication-free therapy (26.4%) and brief 
intervention (17%). Sixty-one cases (3.8%) 
received an alcohol detoxifi cation as a 
main treatment intervention, 57 (3.6%) 
cases completed an education/awareness 
programme, and 8 (0.5%) cases received 
methadone substitution as a main treatment 
intervention.
The client’s condition on discharge was  ■
classifi ed by service providers as stable if they 
had responded to treatment, and unstable 
if they had not responded. Of the 1,586 
cases analysed, 1,099 (69.3%) were stable, 
433 (27.3%) were unstable, 46 (2.9%) were 
classifi ed as ‘other’ and 8 (0.5%) had died. 
Less than half (44%) of cases completed  ■
treatment; 25% refused further sessions or 
did not return for subsequent appointments; 
13.2% did not wish to attend further 
sessions as they considered themselves to be 
stable; 11.3% were transferred to another 
site for further treatment; 4.7% exited 
because of non-compliance, 1.2% exited for 
other reasons, and 0.5% died.
Figure 1 presents the relationship between  ■
clients’ condition on exit (stable or unstable) 
and treatment outcomes. Over half of the 
cases who did not complete treatment 
(clients who considered themselves stable 
and clients who did not return for subsequent 
appointments) were stable on exit.
In relation to the 75 (4.7%) cases who exited  ■
treatment because of non-compliance, the 
reasons recorded were: failure to observe 
rules (60%), drug taking (33.3%), and 
violent behaviour (6.6%). 
The majority of cases (60%) did not have  ■
family members involved in their treatment.
Figure 2 presents the relationship between  ■
the median1 number of days in treatment 
and the main problem substance for the 
698 cases who completed treatment. Half 
of the cases reporting alcohol as their main 
problem substance were in treatment for 
more than 31 days, while half of the cases 
reporting opiates and other stimulants were 
in treatment for more than 67 and 89 days 
respectively. 
Figure 1 Clients’ condition on exit, by treatment outcomes, 2007 
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3Treatment outcomes (continued) 
Figure 3 presents the relationship between the median  ■
number of days in treatment and polydrug use for 
the 698 cases who completed treatment. Of the cases 
reporting a drug as their main problem substance, those 
who used more than one drug spent approximately 
twice as many days in treatment as those reporting 
single substance use. The median number of days spent 
in treatment was the same for all cases who reported 
alcohol as their main problem substance, regardless of 
whether they used other drugs or not.
Exit data for psycho-social treatment interventions have 
become available for the fi rst time in Ireland through the 
completion of the exit form. Analysis shows that treatment 
outcomes in the south east are largely positive. Service 
providers in Donegal, Sligo and Leitrim have agreed to pilot 
the exit form in 2008, and in 2009 the exit form will become 
available to all service providers throughout Ireland. 
(Anne Marie Carew, Martina Kidd, Delphine Bellerose and 
Jean Long)
The NDTRS team would like to express sincere thanks to all 
the service providers who completed the exit form in 2007. 
Their co-operation is very much appreciated.
1. The median is the value at the mid-point in a sequence 
of numerical values ranged in ascending or descending 
order. It is defi ned as the value above or below which 
half of the values lie. Unlike the mean (average), the 
median is not infl uenced by extreme values (or outliers). 
For example, in the case of fi ve drug users aged 22, 23, 
24, 24 and 46 years respectively, the median (middle 
value) is 24 years, whereas the mean is 27.8 years. While 
both the median and the mean describe the central 
value of the data. In this case, the median is more useful 
since the mean is infl uenced by the one older person. 
Figure 2 Median number of days spent in treatment, by main problem drug, 2007 
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The Commencement Order on the Intoxicating 
Liquor Act 2008 was signed on 23 July 2008. The 
purpose of this Act is to amend the Licensing Acts 
1933 to 2004 and the Criminal Justice (Public 
Order) Act 1994 in order to give effect to reforms 
recommended by the Government Alcohol 
Advisory Group.1 
The main provisions in the new Act are as follows: 
Sale of alcohol
Off-sales of alcohol will be restricted to the • 
hours from 10.30 am to 10.00 pm (12.30 
pm to 10.00 pm on Sundays and on Saint 
Patrick’s Day).
Any future applicants for a wine retailer’s • 
off-licence will also require a District 
Court certifi cate. The grounds on which 
the District Court may refuse to grant a 
certifi cate for a spirit, beer or wine retailer’s 
off-licence will be extended. When granting 
a certifi cate, the District Court may also 
impose a condition that a CCTV system be 
installed.
In premises that are engaged in mixed • 
trading, such as supermarkets, convenience 
stores and petrol stations, alcohol products 
must be displayed and sold in a specifi ed 
area that is structurally separated from the 
rest of the premises. As compliance with this 
provision may require structural alterations 
to premises, it is intended to give licensees 
an adequate period of time to make the 
necessary arrangements before bringing it 
into force. 
The grounds on which an objection • 
may be made to the grant of a District 
Court certifi cate for any off-licence will 
be extended to include consideration of 
the needs of the neighbourhood and the 
adequacy of the existing number of off-
licences in the area.
Test purchasing of alcohol products will • 
be permitted in both on- and off-licences; 
appropriate safeguards for the protection of 
the young people concerned will be put in 
place.
Extended opening hours
The conditions under which ‘special • 
exemption orders’ can be made will be 
amended to require the operation of a 
CCTV system and compliance with fi re 
safety standards. The public order ground 
on which objection may be made by the 
gardaí to the grant of such orders is also 
being strengthened.
The sale of alcohol in premises with theatre • 
licences will be permitted only during 
Substance misuse in the HSE 
south eastern area
The Health Service Executive (HSE) South published 
its annual report, Data co-ordination overview of drug 
misuse 2007, in July 2008.1 The report comprises 
three sections: treatment services, education and 
prevention, and supply control. 
The section on treatment services analyses data 
collected from statutory and voluntary drug and 
alcohol treatment agencies, acute general hospitals 
and psychiatric hospitals in the HSE South Eastern 
Area. Data from the drug and alcohol treatment 
services are returned to the National Drug 
Treatment Reporting System in the Health Research 
Board. 
The total number of individuals seeking treatment 
in 2007 was 2,951, an increase of 310 on the 2006 
fi gure. The report notes that there was not full year 
reporting from some services because of retirement 
and illness. Some 223 concerned persons (family 
members or close friends of substance users) 
contacted treatment services in the south east in 
2007, an increase of 108 on the 2006 fi gure. 
The combined total of continuous care clients and 
new referrals who were treated was 2,265. 
Of these: 
69% were male and 31% female.• 
7.1% were under the age of 18, and 43% • 
were aged between 20 and 34. 
Alcohol (64%) was the most common main • 
problem substance for which treatment was 
sought, followed by cannabis (12%) and 
heroin (10%). 
The numbers seeking treatment for alcohol • 
and cannabis decreased since 2006, while 
the numbers seeking treatment for cocaine, 
heroin, MDMA, amphetamines and volatile 
inhalants increased. 
9% of treated clients reported that they had • 
injected a substance at some point in their 
lives, of whom over half (53%) reported 
that they had shared injecting equipment. 
Data presented in this report are useful for planning 
future services. 
(Anne Marie Carew)
1. Kidd M (2008) Data co-ordination overview of 
drug misuse 2007. Waterford: HSE South.
The Intoxicating Liquor Act 2008 
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normal licensing hours, or during extended opening 
hours under a special exemption order granted by 
the District Court. 
Public order
The gardaí will have the power to seize bottles and • 
containers of alcohol in the possession of a person 
who is aged under 18 years. It will be an offence for 
a person, when requested by a garda, to refuse to 
give his or her name, address and age, or to hand 
over the bottle or container, with a fi ne of up to 
€500 on conviction. 
Alcohol promotions and discount sales
Advertising, promoting, selling or supplying alcohol • 
at reduced prices will be prohibited.
Penalties and sanctions
There will be a minimum two-day closure period • 
for temporary closure orders made by the District 
Court on the conviction of licensees for certain 
licensing offences, for example, sale of alcohol to 
a person under 18, or permitting drunkenness or 
disorderly conduct on the premises. Certain fi nes 
in the Licensing Acts 1833 to 2004 and fi nes under 
the Criminal Justice (Public Order) Act 1994 will be 
increased.
The majority of provisions in the Act came into operation 
on 30 July 2008. The provisions relating to test purchasing 
of alcohol products and to structural separation of alcohol 
in supermarkets and convenience stores have not yet been 
commenced. 
(Deirdre Mongan)
1. Government Alcohol Advisory Group (2008) Report of the 
Government Alcohol Advisory Group. Dublin: Department 
of Justice, Equality and Law Reform.
Intoxicating Liquor Act (continued)
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Tackling alcohol misuse in the UK  
The British Medical Association recently published a report, 
Alcohol misuse: tackling the UK epidemic,1 which describes 
drinking patterns and indicators of alcohol-related harm in 
the UK, and considers a range of evidence-based policies to 
tackle problematic levels of alcohol misuse. 
The UK is among the heaviest alcohol consuming countries 
in Europe, with consumption rising from 3.9 litres per capita 
in 1950 to 8.9 litres in 2006. The prevalence of alcohol 
consumption varies considerably by ethnic group. Only 9% 
of the White British population are non-drinkers, whereas 
48% of people of Black African origin and 90% of those of 
Pakistani and Bangladeshi origin abstain from alcohol. While 
the majority of individuals who consume alcohol do so in 
moderation, 23% of men and 12% of women drink above 
the UK recommended limits. The report estimates that 7% 
of the adult population are alcohol dependent. 
Alcohol is causally related to over 60 different medical 
conditions and, in the majority of cases, the risk of disease 
increases with a higher volume of consumption. It has 
been estimated that alcohol misuse accounts for more than 
22,000 premature deaths per year in England, of which 
1,000 are suicides. The alcohol-related death rate in the 
UK almost doubled between 1991 and 2005, from 6.9 to 
12.9 per 100,000 population. The burden of alcohol-related 
mortality is shifting to younger age groups in both men and 
women, and toward the most socially deprived groups. In 
England, the rate of mortality from liver cirrhosis trebled 
between 1970 and 1995, while the rate in the EU decreased 
by 30%. In addition, alcohol was implicated in 17% of road 
deaths in 2006. 
Alcohol misuse is a major cause of admission to hospital 
in both emergency and non-emergency settings. It has 
been estimated that 70% of all admissions to emergency 
departments at peak times are alcohol related. In England, 
the number of hospital admissions of adults aged 16 and 
over with a primary or secondary diagnosis related to alcohol 
use more than doubled, from 89,280 in 1995/96 to 187,640 
in 2005/06. 
Alcohol misuse can lead to many harmful social 
consequences. Approximately half of homeless people are 
alcohol dependent. Parental alcohol misuse is correlated 
with child abuse and signifi cantly impacts on a child’s 
environment. In 2004, it was estimated that between 
780,000 and 1.3 million children were affected by parental 
alcohol problems in England. It has been estimated that 
alcohol misuse results in 17 million working days lost 
annually in England. The total annual societal cost of alcohol 
misuse in England has been estimated at £55.1 billion. 
There has been considerable deregulation and liberalisation 
of alcohol control policies in the UK, which has been 
accompanied by an increase in consumption levels and 
alcohol-related problems. This report criticises the focus of 
the UK government on interventions that are popular but 
ineffective, such as educational programmes and media 
campaigns, and the rejection of policies such as increased 
taxation and reduced availability that have been found to 
reduce alcohol consumption and related problems. It also 
criticises the UK government’s emphasis on partnership 
with the alcohol industry and self-regulation, which has at 
its heart a fundamental confl ict of interest that does not 
adequately address individual and public health. In the 
Licensing Act 2003, which permits 24-hour opening in 
England and Wales, public health was not considered as one 
of the licensing objectives. 
The report calls on the government to show leadership and 
implement a full range of effective evidence-based policies 
that will reduce the burden of alcohol misuse, including:
Higher taxes on alcoholic drinks, proportionate to 1. 
the amount of alcohol in the product. The affordability 
of alcohol in the UK increased by 65% between 1980 
and 2006. Levels of alcohol consumption (particularly 
among heavy drinkers and young drinkers) and related 
problems are responsive to price; it is estimated that a 
10% increase in alcohol price would lead to a 10% fall in 
consumption. 
drugnet 
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Reducing availability.2.  Availability of alcohol 
should be regulated through a reduction 
in licensing hours for on- and off-licensed 
premises. The density of alcohol outlets should 
be taken into account when considering 
planning or licence applications. 
Responsible retailing and industry practices,3.  
including strict enforcement of legislation 
prohibiting the sale of alcohol to intoxicated 
customers and people under the age of 18, 
and the abolition of irresponsible promotional 
activities such as happy hours and two-for-one 
offers. 
Measures to reduce drink-driving.4.  The legal 
limit for the level of alcohol permitted while 
driving should be reduced from 80mg/100ml 
to 50mg/100ml, and random breath testing 
should be introduced.
Early intervention and treatment of alcohol 5. 
misuse. The detection and management of 
alcohol misuse should be an adequately funded 
and resourced component of primary and 
secondary care and include formal screening 
for alcohol misuse, referral for brief intervention 
and specialist alcohol treatment services, and 
follow-up care and assessment at regular 
intervals. 
This report describes the situation regarding alcohol 
in the UK; similar trends can be observed in Ireland, 
where the levels of per capita consumption are even 
higher. It is clear that alcohol misuse is a serious 
problem in both countries and that action must be 
taken to signifi cantly reduce alcohol-related harm. 
This report provides a range of recommendations 
that must be collectively implemented in order to 
effectively tackle alcohol misuse and its associated 
harms; however, this requires strong political 
commitment and leadership. 
(Deirdre Mongan)
1. BMA Board of Science (2008) Alcohol misuse: 
tackling the UK epidemic. London: British 
Medical Association. 
Young people, alcohol and drugs,1 the report of a 
study by Palmer and O’Reilly, was presented at 
an international conference at University College 
Dublin in May 2008. This study compared a group 
of 462 second-level or post-Leaving Cert students 
aged 14–19 (the ‘community group’) to a similarly 
aged ‘clinical group’ of 30 adolescents in residential 
treatment for substance misuse in the south 
and south east of Ireland. The study examined 
substance use behaviour, coping style, motivations 
for alcohol and drug use and family functioning. 
In addition, qualitative interviews were conducted 
with 10 young people from the clinical group. 
In the community group, 86% stated that they 
consumed alcohol; the average age of fi rst alcohol 
use was 13.4 years. The average number of drinks 
consumed on a typical drinking occasion was 5.7, 
ranging from four drinks among 15-year-olds to 
seven among 19-year-olds. One-third stated that 
they drank alcohol at least once a week; there was 
a pattern of more frequent drinking with increasing 
age. Spirits were the most common alcoholic 
drink, consumed by 54%, followed by alcopops 
(47%), cider (42%) and beer (39%). However, beer 
was the most popular drink among males (63%) 
and alcopops was the beverage of choice among 
females (72%). Binge drinking on a weekly basis, 
defi ned as consuming fi ve or more drinks on a 
single drinking occasion, was reported by 23% of 
respondents.
Thirty-eight per cent of the community group 
reported negative consequences of alcohol use. 
Most frequently reported were: getting into an 
argument (20%); trouble at home (18%); accident 
or injury (13%); and a physical fi ght (13%). Males 
were signifi cantly more likely than females to report 
that alcohol use had led to a physical fi ght, had led 
to damage to property, or had resulted in trouble 
with the police. 
Half of the community group reported having used 
an illicit drug, and the average age of fi rst drug use 
was 14.5 years. Cannabis was the most commonly 
reported drug used (41%), followed by inhalants 
(30%), poppers (17%) and cocaine (11%). Regular 
use of cannabis, defi ned as once a month or more, 
was reported by 13%. Negative consequences 
of drug use were reported by 11% of the total 
group. In contrast to consequences of alcohol use, 
performance affected at school/work was the most 
common consequence of drug use (7%). 
Of the 30 participants in the clinical group, four 
met the criteria for an alcohol abuse disorder and 
26 had an alcohol dependent disorder. Polydrug 
use was common, with 27 also meeting the criteria 
for dependence on other substances. This group 
reported a high level of co-existing psychological 
problems. The qualitative interviews identifi ed a 
range of personal and environmental factors as 
infl uential in their initial substance use, including 
poor family functioning, and using alcohol as a 
coping strategy. 
This report identifi es the need for epidemiological 
studies of substance use among young people. 
It recommends further research to evaluate the 
effectiveness of preventative interventions and to 
examine the effi cacy of treatment interventions for 
adolescent substance misuse, including long-term 
follow up in an Irish context. 
(Deirdre Mongan)
1. Palmer D and O’Reilly G (2008) Young people, 
alcohol and drugs. Cork: Juvenile Mental Health 
Matters.
Young people, alcohol and drugs
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The Health Research Board appointed Mr Enda 
Connolly as Chief Executive in June 2008. Mr 
Connolly brings to his new position more than 30 
years’ experience with IDA Ireland, where he had a 
pivotal role in leading change, developing strategy, 
building stakeholder confi dence and securing 
signifi cant foreign direct investment. The new 
CEO will focus on articulating and implementing a 
clear vision and strategic direction for the HRB and 
health research in Ireland in a changing healthcare 
landscape. 
Dr Hamish Sinclair, formerly head of the Drug 
Misuse Research Division, had been Acting Chief 
Executive prior to Mr Connolly’s appointment. He 
will continue in his position as Director of Health 
Information and In-house Research, to which he 
was appointed in 2007.
In May 2008 Eurobarometer published the results 
of a survey of young EU citizens’ attitudes and 
perceptions about the drugs issue.1 The fi eldwork 
was carried out between 14 and 18 May 2008. 
Over 12,000 randomly selected 15–24-year-
olds were interviewed across the 27 EU member 
states. The survey was carried out by telephone, 
with web-based computer assisted telephone 
interviewing (WebCATI).2 The fi ndings relating to 
Irish respondents are summarised below. 
Potential and actual sources of information on 
drugs
Ireland had the highest proportion of respondents 
who would choose to talk to a friend when looking 
for more information about illicit drugs and drugs 
use. Irish young people were also among those 
most liable to talk to their parents or relatives 
about drugs and drug use. While Irish respondents 
favoured talking to a health professional such as a 
doctor or nurse, they clearly did not favour talking 
to a counsellor or someone else at a specialised 
drug centre. When asked about information 
channels used in the past year, Irish respondents 
reported a rather different pattern: they had drawn 
principally on media campaigns, followed by 
friends, and then Internet sources.
Perceived health risks of using drugs
Respondents were asked to rank the health 
risks associated with various substances as high, 
medium or low. Substances seen by most Irish 
respondents as posing a medium or high risk to 
health were heroin (98.7%), cocaine (98.5%) and 
ecstasy (95%).  Smaller percentages of respondents 
regarded as medium or high the risk posed to 
health by tobacco (78.8%), cannabis (74.2%) and 
alcohol (73.5%). Only 12.7% perceived alcohol as 
posing a high risk, while 28.4% deemed tobacco 
and 30.1% deemed cannabis as doing so.
How should society’s drug problems be tackled?
Respondents were asked to rank a series of actions 
that public authorities could take to deal with 
the drug problem as either the ‘most effective’ 
or the ‘second most effective’ way of combating 
the problem. Respondents in Ireland were among 
the least likely to see the clampdown on drug 
dealers and traffi ckers as effective. Conversely, Irish 
respondents were among the most likely to believe 
that the treatment and rehabilitation of drug users 
was an effective way to deal with society’s drug 
problems. Irish respondents (22%), along with 
those in the UK and The Netherlands, were the 
ones who most favoured the legalisation of drugs. 
To ban or regulate illicit drugs, alcohol and 
tobacco?
Substances that most Irish respondents felt should 
continue to be banned were heroin (97%), 
cocaine (95%) and ecstasy (95%). Just 61% of 
Irish respondents believed that cannabis should 
continue to be banned, and 39% believed that it 
should be regulated. With regard to alcohol, the 
largest proportions of respondents who supported 
continued regulation were found in the The 
Netherlands and Ireland (96%); just 4% of Irish 
respondents favoured the banning of alcohol. 
With regard to tobacco, 80% of Irish respondents 
believed that it should continue to be regulated, 
while 20% believed it should be banned.
Access to illicit drugs, alcohol and tobacco
With regard to illicit drugs, Irish respondents were 
among the most likely to say that it was easy to 
obtain heroin, cocaine, ecstasy and cannabis, if they 
wanted to. Young people in Ireland were among 
those most likely to say that they could easily obtain 
alcohol and tobacco. Cross-tabulating respondents’ 
perceptions of the health risks associated with 
drug use and their answers relating to the ease of 
obtaining the drugs showed that young people 
who found it easier to obtain the substances also 
perceived the health risks associated with drug use 
to be less serious. 
(Brigid Pike)
1. The Gallup Organization (2008) Young people 
and drugs among 15–24 year-olds: analytical 
report. Flash Eurobarometer 233. European 
Commission. Retrieved 11 July 2008 at http://
ec.europa.eu/public_opinion/archives/fl ash_
arch_en.htm#233 This survey built on two 
earlier surveys of young people and drugs in 
Flash Eurobarometer on young 
people and drugs 
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8In December 2007 the Dublin Simon Emergency Shelter 
started to implement a methadone programme being 
piloted by the Safetynet service.1 The results of an internal 
evaluation undertaken after the programme had been 
running for six months were presented in a recent report.2
The Shelter provides accommodation to homeless people 
for up to six months. A large majority of residents are 
active drug users, most of them injecting heroin. The 
direct consequences of their drug use include high levels 
of morbidity, often leading to hospitalisation, a signifi cant 
number of evictions from the Shelter for unsafe drug use, 
and generally chaotic drug-using behaviour. Most residents 
were not receiving any form of treatment prior to joining the 
Safetynet programme, partly because of the waiting lists in 
many methadone clinics. Long waiting lists mean that many 
clients are not able to start treatment before their time in 
the Shelter is up, and the opportunity to address their drug 
problem and their homelessness at a time of relative stability 
is lost. 
By providing on-site medical and nursing services, as well 
as a needle-exchange service, the Safetynet methadone 
programme has had a major impact on the residents and 
staff of the Shelter. Fourteen residents started the methadone 
programme during the six-month period. With little more 
additional budget than the standard cost for dispensing 
methadone, the fi rst six months of the programme proved 
to be successful and the evaluation highlighted many 
benefi ts, such as:
marked reduction in drug use• 
marked reduction in morbidity, especially skin • 
conditions and abscesses, largely attributed to the 
decrease in injecting by clients
reduction in the number of evictions• 
reduction in crime involvement• 
improvement in social functioning• 
improved opportunities to move to more permanent • 
accommodation.
The report makes the following recommendations:
Increase the number of places on the programme • 
from 10 to 55, with 25 of those allocated to residents 
of the Shelter.
Facilitate the transfer of clients to HSE drug treatment • 
centres when that is deemed a more suitable option.
Provide an addiction counselling service linked to the • 
programme.
(Delphine Bellerose)
1. Safetynet is a primary care network that provides GP and 
nursing services to homeless people. It was established in 
2007 and is funded by the HSE.
2. Geraghty C, Harkin K and O’Reilly F (2008), Evaluation 
of the Safetynet methadone programme pilot at the 
Dublin Simon Emergency Shelter. Dublin: Dublin Simon 
Emergency Shelter.
Safetynet pilot methadone programme 
evaluated
National Poisons Information Centre – 
2007 report
The National Poisons Information Centre (NPIC), 
located in Beaumont Hospital, provides a national 
telephone information service on the toxicity, features 
and management of cases of poisoning. This 24-hour 
service is offered mainly to doctors and other health care 
professionals. Queries are dealt with by poisons information 
offi cers at the Centre between 8 am and 10 pm, while out-
of-hours calls are automatically diverted to the UK National 
Poisons Information Service (NPIS).
According to its annual report,1 NPIC received 11,011 
enquiries in 2007, a decrease of 7.5% on the 2006 fi gure. Of 
these, 2,459 were dealt with by NIPS in the UK and are not 
included in the analysis presented in the report. Of the 8,552 
calls answered by NPIC, 8,277 (96.8%) were about human 
toxicology. The remaining calls concerned poisoning in 
animals (1.2%) and non-emergency requests for information 
(2.0%). 
Of the 8,552 calls dealt with by NPIC, the highest proportion 
were from the HSE Eastern Region (28.4%), of which 79.8% 
were from Dublin city and county. 
The most frequent enquiries were from hospitals (35.1%), 
general practitioners (34.9%) and members of the public 
(23.0%). The other sources of enquiries were community 
pharmacists, carers, vets, industry/manufacturers, schools, 
emergency services, media, and government agencies. The 
increased use by Irish emergency departments of TOXBASE, 
the online clinical toxicology database of the UK NPIS, is 
refl ected in a 2.2% drop in the proportion of enquiries from 
hospitals since last year. 
Eurobarometer (continued)
the old EU15 in 2002 and 2004 (Special Eurobarometer 
No 172 and Flash Eurobarometer No 158). The topics 
covered ranged from the consumption of various drugs 
and young people’s involvement in the drug culture to 
the dangers associated with various products and young 
people’ opinions about the effectiveness of policies 
aimed at solving society’s drug-related problems.
2. To correct for sampling disparities, a post-stratifi cation 
weighting of the results was implemented, based on 
socio-demographic variables. 
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More than half of the enquiries about cases of poisoning in 
humans concerned children under 10 years of age (Table 
1). The main agents involved in these cases were household 
products, cosmetics and personal hygiene products, and 
plants. The majority (88.5%) of all human poisoning 
incidents occurred in the home.
The enquiries about human toxicology involved 13,538 
agents, mainly drugs, industrial chemicals and household 
products. The most common enquiry concerned substances 
containing paracetamol (1,082). Alcohol was next most 
common (376), and in the majority of cases was ingested 
with other substances. The third most common agent 
was ibuprofen (363). Only a small proportion of cases 
(395, 4.8%) were followed up. Although most recovered 
completely, 21 cases suffered adverse effects, a further 17 
cases died, while the outcome of 68 cases could not be 
determined. 
(Simone Walsh and Suzi Lyons)
For a copy of this report, see the NPIC website at www.
poisons.ie, or telephone 01 837 9964 or 01 809 2566.
1. Poisons Information Centre of Ireland (2008) Annual 
report 2007. Dublin: NPIC. 
NPIC 2007 report (continued)
Age group Gender Total %
Male Female Unknown
<1 159 152 114 425 5.1
1–4 1,921 1,588 66 3,575 43.2
5–9 208 160 7 375 4.5
10–14 80 109 4 193 2.3
15–19 136 241 3 380 4.6
20–49 706 726 9 1,441 17.4
50–69 159 206 3 368 4.4
>70 91 112 1 204 2.5
Unknown 434 499 383 1,316 15.9
Total 3,894 3,793 590 8,277
Table 1 Age and gender of human cases
The second annual conference of the International Society 
for the Study of Drug Policy (ISSDP) took place in Lisbon 
on 3–4 April 2008. It was supported by the European 
Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 
and the Instituto da Droga e da Toxicodependência (IDT). 
The publicly available papers and presentations from the 
conference are listed below.1 
The third annual conference of the ISSDP is planned to take 
place in Vienna on 2–3 March 2009. 
(Brigid Pike)
1. These papers and presentations are available in PDF or 
PowerPoint format at www.issdp.org
Evaluating policy
Development of an Australian drug policy index Alison Ritter
Drug policy in world historical perspective: The fi ve stages of regulation David T Courtwright
Evaluating Danish cannabis policy change Kim Møller
From fundamentalism to technocracy: Learning from Swiss policy failures 
about the fi ght against drug abuse
Sandro Cattacin
Malaysian illicit drug policy: Top-down multi-agency governance or bottom-
up multi-level governance
Balasingam Vicknasingam and 
Suresh Narayanan
Regulating khat – dilemmas and opportunities Axel Klein
The baby, the bathwater and the legacy of normalisation: The role of 
classical and contemporary criminological theory in understanding young 
people’s drug use
Fiona Measham and Michael Shiner
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Modelling
A system dynamics model of Australian opioid pharmacotherapy maintenance 
treatment
Jenny Chalmers, Alison Ritter, 
Mark Heffernan and Geoff McDonnell
Biography of an epidemic: Fentanyl overdose in Chicago Harold Pollack, Greg Scott and 
Sandra Thomas
Optimal timing of use vs. harm reduction in an SA model of drug epidemics Jonathan P Caulkins, Gernot Tragler 
and Dagmar Wallner
Incarceration and testing
Alternatives to what? Drug treatment alternatives as a response to prison 
expansion and overcrowding
Alex Stevens
Drug testing in schools and workplaces: Policy implications and considerations 
of punitive, deterrence and/or prevention measures
Ann M Roche 
Drug testing in schools Howard Taras, Floralynn Einesman 
and Jesse Brennan
Service users to have greater voice in 
the health service 
On 6 May 2008 the National strategy for service user 
involvement in the Irish health service 2008–2013 was 
launched.1 Comprising seven goals, the Strategy will build on 
current good practice in involving service users (i.e. patients, 
their families, voluntary and community organisations) 
across the country.  The goals are outlined as follows: 
Commitment and leadership.1.  Managers and clinicians 
at all levels will demonstrate their commitment to 
the development of service user involvement in the 
planning, development, delivery and evaluation of the 
health services and will report on the implementation of 
the strategy to the HSE Management Team.
A systematic approach to effective service user 2. 
involvement. The planning of service user involvement 
will be carried out in a systematic manner in which 
strategy development and methods of involvement are 
based on a clear understanding of desired outcomes.
Patient involvement in their own care.3.  Models of 
patient care delivery must continue to develop the role 
of the ‘expert patient’, especially those with long-term 
illnesses, in developing their own care plan and in 
looking after their own condition.
A Patients Charter.4.  A rolling programme setting out 
what patients should expect from the health services will 
be developed with service quality standards for service 
users.
Specifi c work will ensure the involvement of children, 5. 
young people and socially excluded groups. All 
involvement work must make specifi c efforts to ensure 
the participation of children, young people and socially 
excluded groups.
Develop existing service user structures.6.  The HSE 
will evaluate existing mechanisms for service user 
involvement to ensure best practice is implemented 
throughout the country.
Performance and development.7.  Learning and 
development programmes aimed at meeting the 
development needs of service users and of health service 
staff will be an integral part of HSE training programmes.
Produced by the Department of Health and Children and 
the HSE in consultation with the Health Services National 
Partnership Forum, HIQA, advocacy groups and service 
users, the principles of the strategy apply to all who use 
health and social services, those who participate in health 
programmes and services and those who work in the health 
service. The HSE will implement the strategy nationally and 
will evaluate its success on an annual basis.
The Patients Charter will be based on models from other 
countries and will provide guarantees of service quality that 
patients can expect when using our health services.2 The HSE 
will develop clear strategic plans to promote and encourage 
service users, particularly those with chronic illnesses, to be 
active participants in their own care. These measures will 
lead to the review of consumer panels (in existence in many 
parts of the country), building on good practice and the 
development of a system of advocacy to support patients 
and clients. 
(Brigid Pike)
1. Department of Health and Children and the Health 
Service Executive, in consultation with the Health 
Services National Partnership Forum (2008) National 
strategy for service user involvement in the Irish health 
service 2008–2013. www.hse.ie/eng/Your_Service_Your_
Say/Documentation/Strategy/Service_User_Involvement.
html
2. With regard to patient charters, action 46 of the National 
Drugs Strategy called for the development of a ‘service-
user charter specifi c to treatment and rehabilitation 
facilities which would lead to a greater balance between 
the service user and the service provider’. Such a 
charter was seen as being particularly benefi cial for 
drug misusers presenting for treatment with low levels 
of educational attainment or low self-esteem. In the 
mid-term review of the National Drugs Strategy, the 
Steering Group recommended that in future, where 
these charters were being developed, services should 
consult more widely with service users in the drafting of 
the charters (para. 5.17).
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Human rights and illicit drugs policy  
The year 2008 marks the 60th anniversary of the signing 
of the Universal Declaration of Human Rights (UDHR) as 
well as the conclusion of the UN’s 10-year action plan on 
drugs. Several international non-governmental organisations 
(NGOs) have taken the opportunity to set out their policy 
positions on the relationship between human rights and 
drug control, as has the Commission on Narcotic Drugs 
(CND), the central policy-making body of the UN in 
drug-related matters. There has been some debate on the 
relationship between the two policy domains in Ireland.
International NGOs
The International Drug Policy Consortium has called for 
the drug control agencies to clearly condemn any activities 
undertaken in the pursuit of drug control that contravene 
international human rights and judicial standards.1 The 
International Harm Reduction Association has gone further, 
calling for international human rights commitments and 
obligations to be used to support the promotion of harm 
reduction programmes and the rights of people who use 
drugs to respect and dignity.2 The Beckley Foundation Drug 
Policy Programme has highlighted the inconsistencies and 
contradictions between the international human rights and 
drug control systems, and has called for greater system-
wide cohesion.3 The authors note that the human rights 
obligations imposed on UN bodies and member states in the 
UN Charter override any confl icting obligations in any other 
international agreement. 
Commission on Narcotic Drugs 
In March 2008, at the 51st session of the CND, which 
saw the launch of the year-long review of the UN 10-year 
action plan, the CND passed a resolution reaffi rming that 
countering the world drug problem must be carried out 
in full conformity with the purposes and principles of the 
UN Charter and other provisions of international law and, 
in particular, with full respect for, among other things, all 
human rights and fundamental freedoms, and on the basis 
of the principles of equal rights and mutual respect.4 
Ireland
The Working Party on Drug Abuse, which reported in 1971, 
is the only body tasked with developing national policy 
on illicit drugs in Ireland to have explicitly mentioned the 
rights of the drug user: in the context of supply reduction 
measures, the working party commented that there 
should be ‘no undue interference with the freedom of 
the individual as far as any changes in procedures relating 
to search and arrest’ (para. 3.2).5 In the mid 1990s Tim 
Murphy, in a critique of Ireland’s prohibitionist drug policy, 
commented that ‘another highly signifi cant social cost 
of drug prohibition is the abuse of civil liberties which 
inevitably accompanies the active criminalisation of basically 
“victimless” conduct’ (p. 54).6 He cited the discussion in the 
Government strategy to prevent drug misuse (1991) about 
the detention of individuals suspected of concealing drugs 
in body cavities, and the provision for seven-day detention 
for suspected drug dealers in the Criminal Justice (Drug 
Traffi cking) Act 1996, as examples of ‘active criminalisation’. 
In a recent publication, in which he makes a case for the 
abolition of drug prohibition in Ireland, Paul O’Mahony 
argues that individuals have a right to use drugs.7 Far from 
promoting a laissez-faire approach to this human right, 
O’Mahony argues that implementation of this right would 
bring two sets of gains– ‘negative’ gains by eliminating 
or at least diminishing the ills associated with prohibition, 
and ‘positive’ gains by changing the relationship between 
citizens and the state, and thereby strengthening the impact 
of drug education, treatment and social relations.
In 2007, in a report released to coincide with the 60th 
anniversary of the UDHR, the Irish section of Amnesty 
International assessed the ‘reality’ of human rights in 
Ireland.8 The report described how Ireland has championed 
human rights on the international stage but identifi ed areas 
at home where the Irish state ‘has not respected, protected 
or fulfi lled all rights or the rights of all’ (p. 1). The report 
suggested that these gaps were the result of the state’s 
failure to follow human rights principles in its planning 
and decision-making processes. While drug users were not 
included among the ‘vulnerable groups’ considered in this 
report, drug use was mentioned as an exacerbating factor 
among those experiencing human rights violations because 
of imprisonment or homelessness. Amnesty International 
concluded its report with a series of recommendations on 
how Ireland could move towards a human-rights-based 
approach in its social and economic policies. 
In 2007 the Irish Human Rights Commission announced in 
its strategic plan for 2007–2011 that, as well as continuing 
to review relevant legislation, its strategic focus would now 
be to infl uence policy formulation and legislative drafting 
at an earlier stage than hitherto:9 ‘The Commission believes 
that by encouraging Ministers and civil servants to place 
increasing emphasis on human rights at policy development 
and “heads of bill” stages, it can be more productive and 
effi cient in shaping relevant sections of legislation’ (p. 22). 
(Brigid Pike)
1. International Drug Policy Consortium (2008) The United 
Nations review of global policy on illegal drugs – an 
advocacy guide for civil society. Version 3. Retrieved on 5 
August 2008 at www.idpc.org.
2. Lines R and  Elliott R (2007) Injecting drugs into human 
rights advocacy. Editorial. International Journal of Drug 
Policy (18/6): 453–457.
3. Barrett D, Lines R, Schleiffer R, Elliott R and Bewley-
Taylor D (2008) Recalibrating the regime: the need for 
a human rights-based approach to international drugs 
policy. Report Thirteen. The Beckley Foundation Drug 
Policy Programme. Retrieved on 5 August 2008 at www.
beckleyfoundation.org/policy/ 
4. Commission on Narcotic Drugs (2008) Report on the 
fi fty-fi rst session (28 November 2007 and 10–14 March 
2008). Economic and Social Council Offi cial Records, 
2008, Supplement No. 8. E/2008/28, E/CN.7/2008/15. 
Retrieved on 5 August 2008 at www.unodc.org/unodc/
en/commissions/CND/index.html 
5. Working Party on Drug Abuse (1971) Report of 
working party on drug abuse. Dublin: Stationery Offi ce. 
Retrieved on 5 August 2008 at www.ndc.hrb.ie/
attached/643-0601.pdf 
6. Murphy T (1996) Rethinking the war on drugs in Ireland. 
Cork: Cork University Press. p. 54
7. O’Mahony P (2008)The Irish war on drugs: the seductive 
folly of prohibition. Manchester: University of Manchester 
Press.
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8. Amnesty International–Ireland (2007) Mind the gap: 
human rights and human dignity in Ireland. Retrieved on 5 
August 2008 at www.amnesty.ie 
9. Irish Human Rights Commission (2007) Promoting and 
protecting human rights in Ireland: strategic plan 2007–
2011. p. 22. Retrieved on 5 August 2008 at www.ihrc.ie 
Drug treatment and employment  
McIntosh et al. report on an analysis of follow-up data 
collected in the course of the Drug Outcome Research in 
Scotland (DORIS).1 The data were collected at the DORIS 
4 stage, 33 months from baseline data collection. The 
study found that recovering drug users who had received 
assistance that was specifi cally employment-related were 
three times more likely to have found paid employment than 
those who had received no such assistance.
Of a total study population of 695 at 33-month follow-
up, 140 respondents (20%) said that they had had paid 
employment since their interview at 16-month follow-up 
(DORIS 3 stage). 
The analysis identifi ed, through logistic regression 
modelling, which aspects of the treatment process facilitated 
or promoted the achievement of paid employment by 
recovering drug users. The co-variable that had the 
strongest independent association with the achievement 
of paid employment was the individual’s receipt of focused 
assistance from their treatment agency to obtain a job, 
employment skills or education. The analysis also showed 
there was a non-signifi cant relationship between the 
different treatment modalities and the achievement of paid 
employment. 
These are useful fi ndings in the context of the 
recommendations of the Working Group on Drugs 
Rehabilitation,2 which endorses the role of employment-
focused training for recovering drug users in treatment. 
Currently, the main vehicle for such training is the FÁS 
Special Community Employment scheme; however, 
reviews by Bruce3 and Lawless4 highlight the limitations 
of this intervention. Both reviews concluded that, rather 
than focusing on the original, vocational objectives of the 
scheme, the intervention was mainly fulfi lling a supportive 
therapeutic function. 
One intervention that has shown effectiveness in improving 
employment prospects for recovering drug users is the 
customised employment supports (CES) model. This model 
involves a skilled vocational counsellor working intensively 
with a small caseload of clients to overcome the vocational 
and non-vocational barriers that hinder employment.5 
Consideration should be given to piloting the CES model 
in local drugs task forces areas, or adapting the FÁS model 
to include CES elements, to provide viable options for 
individuals who want to work with a more intensive model. 
Service providers should not be disheartened that the 
objective of progressing recovering drug users into paid 
employment may not be achieved at the fi rst attempt, even 
when education and skills are improved and employability 
has been enhanced. Some recovering drug users may wish 
to take a more gradual approach to entering the labour 
market and can be supported in a phased but structured 
way. This report discusses the option of using intermediate 
employment models that reintroduce individuals to the 
discipline and routines of the workplace in a gradual way, 
and provide them with evidence of their competence and 
reliability to present to prospective employers. 
Improving the employability of recovering drug users should 
become a key component of drug policy and practice. 
Research has identifi ed a number of ways in which being in 
paid employment can contribute to an individual’s ability to 
create and sustain a drug-free life. According to this report, 
being in paid employment 
enables the recovering drug user to fi ll his or her • 
time constructively 
promotes economic independence• 
helps reintegration to wider society by removing the • 
individual from the drug-using network and towards 
drug-free social relationships
enhances self-esteem and helps build new sense of • 
self, which protects against relapse
conveys status, which acts as an important symbol to • 
the individual of their ability to return successfully to 
a conventional life. 
It is encouraging for policy makers and service providers 
that the evidence base for effective interventions to improve 
employability for recovering drug users is increasing. 
Ultimately, this evidence can contribute to the development 
of effective care plans for recovering drug users and form an 
important element in the future of drug rehabilitation and 
drug-related social reintegration in Ireland. 
(Martin Keane)
1. McIntosh J, Bloor M and Robertson M (2008) Drug 
treatment and the achievement of paid employment. 
Addiction Research and Theory, 16(1): 37–45.
2. Working Group on Drugs Rehabilitation (2007) National 
Drugs Strategy 2001–2008: Rehabilitation. Report of 
the Working Group on Drugs Rehabilitation. Dublin: 
Department of Community, Rural and Gaeltacht Affairs.
3. Bruce A (2004) Drugs task force project activity for FÁS 
Community Employment and Job Initiative participants. 
Dublin: FÁS. 
4. Lawless K (2006) Listening and learning: evaluation of 
Special Community Employment programmes in Dublin 
North East. Dublin: Dublin North East Drugs Task Force. 
5. For a description of the model and its evaluation, see 
Keane M (2007) Innovative job placement model for 
methadone-maintained clients. Drugnet Ireland, (24): 
7–8. 
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Bridge-to-Workplace inter-agency 
initiative
On 26 May 2008, the operational management 
group of the Bridge-to-Workplace project launched 
its progress report.1 Bridge-to-Workplace is an 
inter-agency initiative aimed at facilitating the 
reintegration of individuals with a history of illicit 
drug use through a programme of training and 
work experience.
This project is seed funded by FÁS and the Finglas 
Cabra Local Drugs Task Force. The other agencies 
involved are: Ballymun Job Centre Co-operative, 
Blanchardstown Local Employment Service Network 
(LESN), Dublin Inner City Partnership, Finglas Cabra 
Partnership LESN, HSE Rehabilitation/Integration 
Service (RIS), Inner City Employment Service, and 
Northside Partnership LESN.
Customised reintegration plan
The primary aim of Bridge-to-Workplace is to 
facilitate access to mainstream education and to 
provide clients with work placement opportunities. 
The project also provides a wider range of 
services, such as counselling, life-skills training, 
career guidance and housing support. Clients 
referred to the project must be drug free (unless 
on methadone maintenance), stable, motivated 
and committed. Key workers from both the 
employment and the rehabilitation services assess 
and agree on a client’s suitability. A progression 
plan is developed based on the client’s needs, 
interests, stability and skills, and this plan is 
monitored and reviewed on an ongoing basis 
through three-way meetings with the client and RIS 
and LESN offi cers. 
Between August 2005 and December 2006, a total 
of 74 clients participated in the programme, of 
whom 39 (52.7%) have completed or are presently 
engaged in a work placement. The majority of 
placements have been within the commercial 
sector, lasting between two and 25 weeks, with 
an average of 12 weeks. Feedback from team 
members, employers and clients has been very 
positive and participants have referred to their work 
experience in terms of increased confi dence and 
motivation, and as a catalyst for progression.
A multi-agency model
By combining the expertise of two key agencies, 
Bridge-to-Workplace provides a more cost-effective 
and cohesive service to address the complex and 
multiple issues presented by the target group. 
This holistic approach and the provision of daily 
or weekly support throughout each individual 
progression plan require a high level of integration 
and co-operation. The implementation of practical 
protocols was paramount to the development of 
an effective and transparent working relationship 
between agencies. While this collaborative effort 
allowed ongoing assessment of the clients’ stability 
and motivation, appropriate timing of training or 
placement and prompt identifi cation of potential 
issues, it also highlighted the political and practical 
diffi culties to be overcome. 
Bridge-to-Workplace offers a valuable insight into 
the challenges and benefi ts of an inter-agency 
approach, and has the potential to set standards 
for a more integrated service provision for the 
social reintegration of individuals with a history of 
problem drug use.  
(Delphine Bellerose and Vivion McGuire)
1. Bridge-to-Workplace (2008) Bridge-to-
Workplace: an inter-agency initiative. Working 
together: progress report. Dublin: Bridge-to-
Workplace. Available at www.fcp.ie.
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The Killinarden Drugs Primary Prevention Group (KDPPG) 
established the WRENS1 project in 2002, initially to assist 
women who experienced marginalisation from their 
communities as a result of the anti-social behaviour of a 
family member. Based on the principles of community 
development, the project has continued to work with 
parents and families and has developed specifi c services 
for young people within the school system and for clients 
of the Probation Service. The work of WRENS was recently 
evaluated by Duggan2 using documentary analysis and in-
depth interviews with project staff, parents, school staff and 
probation and welfare personnel. 
According to parents and school staff, the programme for 
young people is contributing to a reduction in disruptive 
behaviour and improvements in school retention rates. 
Disruptive behaviour and early school leaving are indicators 
of drug use and, in this context, the programme is seen to 
benefi t young people at risk of engaging in drug use. In 
particular, the intensive one-to-one work with young people 
was identifi ed as an effective approach. 
Participants in the family programme reported having 
gained a better understanding of the issues adversely 
affecting them, improved problem management techniques 
in the family, increased participation in the community 
and in some cases the attainment of new skills applicable 
to a range of settings. However, the evaluation noted that 
some parents were potentially becoming dependent on 
the support from the programme and that, in the long run, 
measures ought to be taken to empower these parents to 
progress to independent management of the issues affecting 
them. 
Among the small number of participants who were 
supervised by the Probation Service, a number of notable 
changes in behaviour and lifestyle were reported. For 
example, participants reported a greater awareness of the 
consequences of their offending behaviour and of ways 
of changing such behaviour. They also reported greater 
structure in their lives, increased awareness of alcohol and 
drug addictions and improved relations with the Probation 
Service. 
Overall, the evaluation reported that KDPPG, through the 
WRENS project, was doing excellent work in delivering 
community development interventions to individuals and 
families with specifi c needs. These interventions benefi ted 
the individuals, the families and their communities, and 
added value to the work of the statutory sector. However, 
it was noted that the KDPPG could improve its strategic 
planning and begin systematic data collection so as to 
monitor and evaluate its own service and to share its 
experience with other agencies responding to drug use. 
A lack of strategic planning and systematic data collection 
is common among drug prevention interventions based on 
community development principles. This is often infl uenced 
by the fl uid and organic nature of community development, 
where the aim is to empower individuals and families 
through face-to-face interventions in the community so 
that they can resolve their own problems and contribute 
to greater community cohesion, rather than to provide 
evidence of effectiveness.  
(Martin Keane)
1. WRENS stands for Women Reviewing Equality 
Networking Standards.
2. Duggan C (2007) An evaluation of the WRENS project 
implemented by KDPPG. Dublin: Killinarden Drug Primary 
Prevention Group. 
An evaluation of the WRENS project in 
Killinarden  
The Drug and Alcohol Programme (DAP) run by Crosscare 
works with small numbers of individuals referred either 
by the courts or by their legal teams for drug education 
following arrest for fi rst-time and minor drug-related 
offences. Such offences often occur in the context of 
outdoor concerts and music festivals. Crosscare recently 
commissioned research to investigate two key questions: 
Is the DAP service the appropriate mechanism to meet  ■
the needs of this target group and, if so, how can it be 
developed further? 
What is best practice in meeting the needs of this target  ■
group? 
This research has now been published, and draws attention 
to an area that has received little attention so far.1 The report 
notes that in 2007 fewer than fi ve individuals referred to 
the DAP had been arrested for minor cannabis or ecstasy 
offences at music festivals. However, this number may be 
an underestimate as the DAP does not usually record the 
reasons for referral. It is claimed that individuals are often 
referred to the programme on an ad hoc basis, with no clear 
links developed between the courts and the drug education 
providers and no attempt to monitor or evaluate the service. 
The report recommends improved collaboration between 
the courts, the Probation Service and drug education 
providers, and questions whether the current service run by 
Crosscare is the appropriate mechanism, in the absence of 
the necessary collaborative supports outlined. 
The author states that drug education is unlikely to be 
effective unless it is begun at the point of arrest and set 
within the context of a continuum of care from fi rst point of 
engagement through treatment and into recovery. However, 
this claim is made on the basis of fi ndings from one study2 
of drug arrest-referral schemes in the UK which dealt with 
problematic drug users requiring treatment, rather than with 
recreational drug users referred to drug education services 
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as in the Crosscare programme. Individuals arrested for 
fi rst-time or minor drug-related offences are unlikely to share 
characteristics or needs with the kind of clients dealt with by 
arrest-referral schemes such as those in the UK study. Drug 
education plays a peripheral part in such schemes, where 
the main focus is on getting individuals into treatment as an 
alternative to a custodial sentence.
The Crosscare report recommends that the best way to 
meet the drug education needs of recreational drug users 
in Ireland is through multi-agency partnerships, so that 
participants can be referred to appropriate services, such as 
drug treatment, housing support, mental health, primary 
care, training, education and employment. The author 
concludes that a UK programme, Dependency to Work 
(D2W), is a model of best practice in this regard and that 
agencies such as Crosscare could draw on the approaches 
adopted in the model if they wish to continue providing a 
service to individuals referred by the courts. 
The comparison between the DAP and the D2W is 
inappropriate because the D2W programme was developed 
to target offenders with multiple complex needs, including 
problematic drug use; it was not designed to engage 
with individuals arrested for once-off, minor drug-
related offences. Therefore, one can argue that the D2W 
programme is not a suitable model for dealing with the 
small numbers of individuals referred by the courts and 
engaging with the DAP. 
An evaluation of the D2W programme over the fi ve-year 
period 1999–2004 concluded that it was only partially 
successful. While the programme succeeded in getting 
some clients into drug treatment, it suffered implementation 
failure, with relations between the statutory and voluntary 
sectors becoming strained around issues such as assessment 
protocols and the sequencing of service delivery and 
programme management, with different actors pursuing 
targets that often confl icted with those of the D2W 
programme. Because of differences between the target 
groups and weakness within the D2W programme itself, it 
would appear that this is not an appropriate example of best 
practice in the case of the DAP programme. 
(Martin Keane)
1. Giaquinto F (2008) Court appointed drug education: the 
perspective of the voluntary sector. Dublin: Crosscare.
2. O’Shea J and Powis B (2003) Drug arrest referral schemes: 
a case study of good practice. London: Home Offi ce 
Research Development and Statistics Directorate.
3. McSweeney T and Hough M (2006) Supporting 
offenders with multiple needs: lessons for the ‘mixed 
economy’ model of service provision. Criminology and 
Criminal Justice. 6(1): 107–125.
George’s Hill Step-Down programme for 
recovering drug users
In 2004, the Health Service Executive Rehabilitation/
Integration Service (RIS) and the Keltoi residential drug 
rehabilitation service recognised that some people who 
had taken part in drug rehabilitation in Keltoi did not have 
a secure and safe living environment to return to and were 
exposed to the risk of relapse. Also, some were not ready 
to move to independent living after rehab and needed the 
help of supported accommodation. Keltoi clients reported 
diffi culties in sustaining accommodation, and at least two-
thirds experienced episodes of homelessness. In response, 
the RIS and Keltoi, in conjunction with Focus Ireland, a 
voluntary service provider to the homeless, developed an 
inter-agency response, known as the George’s Hill Step-
Down programme, providing six months’ supported 
accommodation.
The Step-Down programme has seven self-contained 
apartments. Clients are responsible for payment of rent 
and other domestic services such as electricity and phone 
bills. A tenancy support worker is available to clients for six 
months after they leave George’s Hill. The RIS continues to 
work with individuals for at least one year to assist them 
to access further education, training or employment. 
Support is provided by a key worker, a caseworker, aftercare 
sessions and monthly review meetings. Day-time vocational 
programmes and facilitated group sessions are also provided. 
The latter include modules on practical skills, education, 
and stress management, managing accommodation, 
communication and health care. 
The results of an external evaluation of the programme in 
2007 have now been published.1 Data were collected from 
10 former and current clients, and from staff members of the 
three partner agencies, using semi-structured interviews. 
Between the time of its launch in September 2005 and 
August 2007, 15 clients participated in the programme, of 
whom 12 completed and three left before the end of the 
six months. A further seven clients were on the programme 
during the evaluation period in 2007. Of the 22 former and 
current clients, 15 (68%) were male, 15 (68%) were in the 
26–40 age group, and the majority (18) were single. 
Of the 12 clients who had completed the programme, six 
were living independently, two were living with a family 
member or a partner and four were living in transitional 
housing. In addition, the evaluation reported that anecdotal 
information gathered by Focus Ireland key workers, either 
through direct contact with former clients or through 
RIS and Keltoi sources, suggested that all former clients 
remained drug free and all were in education, training, 
employment or were travelling. 
(Martin Keane)
1. Juniper Consulting (2008) Step-Down programme, 
George’s Hill: evaluation report. Dublin: Focus Ireland.
Court-prescribed drug education (continued)
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Research by Mayock and Carr1 highlights, once again, the 
association between substance misuse and homelessness. 
This research was designed to generate in-depth knowledge 
and understanding of the experiences of homelessness 
among young people in the south of Ireland, particularly in 
Cork city.
Life-history interviews were conducted with 37 young 
people (20 males and 17 females) between April and 
October 2006. Participants ranged in age from 16 to 
25 years and were recruited from residential settings, 
emergency hostels, drop-in centres and the street. Aspects of 
the group profi le were:
Twenty reported a history of state care. ■
Seven were either parents (3) or expectant parents (4).  ■
Five reported a learning disability and had attended a  ■
special school.
Ten had left school without formal qualifi cations.  ■
The majority (21) described themselves as unemployed. ■
Nine were attending a skills training scheme (FÁS). ■
Twenty-four reported depression; 20 reported substance  ■
misuse; 15 reported stress or anxiety; 13 reported one or 
more episode of self-harm; and six reported attempted 
suicide. 
Study objectives and key fi ndings 
The fi rst objective was to identify young people’s pathways 
into homelessness. Four distinct pathways were identifi ed: 
Having spent time in state care (13 participants)  ■
Features of this pathway were multiple care placements 
in residential and/or foster care, inadequate preparations 
for leaving the care setting and lack of aftercare.
Abusive family situation (10 participants)  ■
Characterised by abuse or violence directed at the 
respondent, or between other family members, creating 
an unstable environment. 
Family confl ict (10 participants)  ■
Typically, these accounts described diffi cult relationships 
within the family home, often with a parent, and 
sometimes of long standing.
Problematic behaviour (4 participants)  ■
Accounts described patterns of behaviour that led 
to family relationship problems, including problem 
substance use, criminal activity, gambling and 
aggression.
A second objective was to examine participants’ experiences 
of living out of home. The experiences reported were 
characterised by movement from one insecure setting 
to another, resulting in instability and insecurity. For 
example, participants reported running away from home 
and care placements, diffi culties with living in different 
accommodation settings and problems with tenancy 
sustainment in private rented accommodation. The majority 
of participants who accessed adult hostels experienced a 
sense of stigma, which confi rmed a homeless identity for 
some. Substance misuse issues, mental health issues and 
learning diffi culties often predominated when young people 
were exposed to this setting. Six participants reported 
moving between prisons and psychiatric hospitals, and some 
reported a pattern of movement between Ireland and the 
UK. 
A third objective was to examine the challenges young 
people experience on becoming homeless. One of the main 
challenges facing participants was their use of alcohol and 
illegal substances. All except one of the 37 participants had 
consumed alcohol at some point. Thirty-one had used an 
illegal drug at some point, of whom two-thirds reported the 
use of four or more substances in their lifetime. Nine had 
used heroin but only two were current users. The early- to 
mid-teenage years was the peak period of initiation for both 
alcohol and illegal drug use. Substance use was associated 
with coping mechanisms: some participants, particularly 
those in hostels, tended to drink and use drugs to ‘pass the 
time’; and many used substances to counteract anxiety and 
depression. Some reported using substances to ‘chill out’ 
with peers, and stated that managing their use of alcohol 
and drugs was important as they did not want to develop 
the kind of negative relations with these substances that they 
had often seen in their parents. A total of 22 reported either 
past or ongoing problems with their use of alcohol and/or 
drugs. 
In general, substance use did not emerge as a factor 
leading to homelessness for the majority of the young 
people. However,it did exacerbate the challenges faced 
by some participants in their efforts to secure and sustain 
accommodation, and often caused crises with regard to their 
tenancies. 
(Martin Keane)
1. Mayock P and Carr N (2008) Not just homelessness: a 
study of ‘out of home’ young people in Cork city. Cork: 
Health Service Executive South.
A study of ‘out of home’ young people in 
Cork city
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Correlation, the European network on social 
inclusion and health, published a protocol for 
collecting data on harm reduction services in 
May 2008.1 The main purpose of this protocol is 
to increase the reliability and comparability  of 
information on harm reduction across Europe by 
using standardised methods to collect data on 
availability of and access to services.
The core element of the protocol is an agency 
inventory, a questionnaire to be completed by 
each agency describing its operational framework, 
characteristics and services provided. The inventory 
includes administrative information on staffi ng, 
management and funding, and data on the range 
of facilities and services offered, quality standards 
and data-collection routines. It also contains 
information on the target population and on new 
drug-use patterns that have come to the attention 
of the agency’s staff in the course of their work 
with current drug users. The protocol includes a 
technical section that gives instructions on how to 
complete the inventory and defi nes the terms used. 
Part I of this booklet outlines the development 
and piloting of the protocol. It lists core services 
representing different areas of activity at harm 
reduction agencies across Europe and describes 
different approaches to monitoring the level of 
access to these services. It also describes the fi eld 
test conducted in Summer/Autumn 2007 with 15 
voluntary agencies from Austria, Bulgaria, France, 
Hungary, Spain, Poland and Portugal, as well as 
by the main harm reduction agency in Iran, and 
presents an evaluation of the results. Part II contains 
the fi nal version of the data-collection protocol. 
(Jean Long)
1. Working Group on Data Collection within the 
Correlation network (2008) Data collection 
protocol for specialist harm reduction agencies. 
Amsterdam: Foundation Regenboog.
Substance use among Irish women 
expecting their ﬁ rst baby
Between April 2003 and May 2004 Donnelly and 
colleagues interviewed 1,011 Caucasian women 
attending a maternity hospital in Dublin city centre 
to determine their use of illegal drugs, tobacco and 
alcohol.1 The defi nition of illegal drugs used in the 
survey is not presented in the published paper. The 
study participants were expecting their fi rst baby, 
were less than 20 weeks pregnant and were aged 
between 16 and 40 years. They were interviewed 
at private, semi-private and public antenatal clinics. 
The study response rate was very high, at 95%.
Of the 1,011 women interviewed, 235 (23.5%) 
reported that they had taken an illegal drug at 
some point prior to this pregnancy. As expected, 
cannabis was the most commonly used illegal drug, 
with 214 respondents (21.2%) reporting that they 
had used it at some point prior to this pregnancy. 
Seventy respondents (6.9%) had used ecstasy at 
some point prior to this pregnancy, while 64 (5.8%) 
had used cocaine. Ninety women (8.9%) had used 
more than one illegal drug prior to this pregnancy. 
Eleven women (1.1%) had used an illegal drug 
during this pregnancy. 
In relation to tobacco use, 574 (57%) of the 
women interviewed reported that they had smoked 
cigarettes at some point in their lives; 282 (28%) 
reported that they were current smokers, of whom 
87 smoked more than 10 cigarettes a day. 
In relation to alcohol use, 545 women (54%) 
said that they had drunk alcohol on at least one 
occasion since their fi rst positive pregnancy test, of 
whom 500 (91.7%) had drunk between one and 
four units, 33 (5.1%) between fi ve and 10 units and 
12 (2.2%) more than 10 units. 
Alcohol consumption and cigarette smoking were 
associated with illegal drug use: smokers were 
2.8 times more likely to use illegal drugs than 
non-smokers, while women who drank alcohol 
were 1.8 times more likely use illegal drugs than 
non-drinkers. The type of clinic attended or the 
level of education achieved were not associated 
with the use of illegal drugs. High levels of alcohol 
use among pregnant women in Ireland has been 
reported elsewhere. 
This survey does not report confi dence intervals 
so it is not possible to estimate the prevalence of 
substance use among the population of women 
expecting their fi rst baby. 
(Jean Long)
1. Donnelly JC, Cooley SM, Walsh TA, Sarkar R, 
Durnea U and Geary M (2008) Illegal drug use, 
smoking, alcohol consumption in a low-risk 
Irish primigravid population. Journal of Perinatal 
Medicine, 38: 70–72. 
European data-collection protocol 
for harm reduction agencies
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Of the 54 new HIV cases among injecting drug users 
reported to the HPSC in 2007, 35 were male and 15 were 
female and the average age was 31 years. All 39 cases for 
whom place of residence was known lived in the HSE Eastern 
Region (Dublin, Kildare and Wicklow). 
This HPSC report confi rms the need, emphasised by the 
authors of the report on the 2004 data, to continue to 
promote the use of harm reduction measures among 
injecting drug users. 
(Jean Long)
1. Health Protection Surveillance Centre (2008) Newly 
diagnosed HIV infections in Ireland: quarters 3 & 4 2007, 
and 2007 annual summary. Dublin: Health Service 
Executive. 
2. Long J (2006) Blood-borne viral infections among injecting 
drug users in Ireland, 1995 to 2005. HRB Overview Series 
4. Dublin: Health Research Board.
New data on the incidence of HIV
Figure 1 Actual number and rolling average number of new cases of HIV among injecting drug users, 
by year of diagnosis, reported in Ireland, 1986 to 2007 
Source: Long (2006)2
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HIV (subsequently known as HIV1) was identifi ed in 1981 
and HIV2 was identifi ed in 1986. The virus attaches itself to 
the CD4 particle of the T-lymphocytes. These T-lymphocytes 
co-ordinate the body’s immune response. HIV may lead to a 
condition known as acquired immunodefi ciency syndrome 
(AIDS). This condition generally occurs when the CD4 count is 
below 200 per millilitre and is characterised by the appearance 
of opportunistic infections. Such infections take advantage 
of a weakened immune system. The HIV virus is found in all 
body fl uids and is transmitted via sexual intercourse (both 
heterosexual and homosexual), mother to foetus and baby, 
infected blood and blood products and procedures with 
unsterile needles, syringes and skin-piercing instruments. Best 
evidence available to date indicates that once an individual is 
infected he or she remains infected for life. 
Voluntary linked testing for antibodies to HIV has been 
available in Ireland since 1985. According to the most recent 
report of the Health Protection Surveillance Centre (HPSC), 
at the end of 2007 there were 4,781 diagnosed HIV cases 
in Ireland, of which 1,381 (29%) were probably infected 
through injecting drug use.1 
Figure 1 presents the number of new cases of HIV among 
injecting drug users, by year of diagnosis, reported in 
Ireland; data from 1982 to 1985 were excluded from 
the fi gure as these four years were combined in the 
source records. Figure 1 is based on data reported to the 
Department of Health and Children, the National Disease 
Surveillance Centre and its successor, the HPSC.2 There was 
a fall in the number of new cases between 1994 and 1998, 
with about 20 cases per year, compared to about 50 cases 
each year in the preceding six years. In 1999 there was a 
sharp increase, which continued into 2000, with 69 and 83 
new cases respectively. Annual fi gures for the next seven 
years were lower than the 2000 fi gure, but did not return 
to the levels of the mid-1990s. It was diffi cult to interpret 
the trend because of the relatively small numbers diagnosed 
each year, so a smoother curve (red plot line in Figure 1) 
was calculated using a rolling centred three-year average. 
This curve presents a true increase in the annual number of 
HIV cases in 1999; this higher level of cases was sustained 
between 2000 and 2007 and a new baseline derived. 
18
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On 19 May 2008, the Blood Borne Virus Forum (BBVF) 
marked World Hepatitis Day with an Open Day at the 
premises of the voluntary agency Community Response in 
Dublin 8. The purpose of the event was to raise awareness 
about hepatitis in general and hepatitis C in particular. 
Service users and health and social care professionals 
attended the Open Day. Nicola Perry from Community 
Response and Olivia Carr from the BBVF welcomed 
everyone. Dr Shay Keating from the Drug Treatment Centre 
Board at Trinity Court applauded the positive work of 
Community Response and other voluntary agencies over 
the last 10 years in raising awareness about hepatitis C. 
Attention was drawn to the fact that almost 20,000 Irish 
people could be infected with hepatitis C, and most do not 
know that they are infected. Information on the symptoms 
of hepatitis C, its routes of transmission, and testing and 
treatment procedures was provided using educational 
posters, leafl ets and interactive activities. 
Two short fi lms, Hidden I and Hidden II, were shown. Both 
were produced by Community Response Drama Group and 
developed through improvisation and role play. Hidden I 
is an educational drama about drug use, pregnancy and 
hepatitis C, while Hidden II continues the story and educates 
the viewer about testing and treatment for hepatitis C. 
A new hepatitis C awareness board game, called Hidden, 
and DVD were launched at the event. The board game can 
be played by up to 10 people and requires players to answer 
a possible 29 questions about hepatitis C. The questions are 
divided into three topics:
Basic information• 
Testing, treatment, sex and pregnancy • 
Social, health promotion and support. • 
There were opportunities for people to play the board game 
on the day and to test their knowledge of hepatitis C. 
Dara Ryan of Roche Products Ireland launched postcards 
which provided information on the risk factors for hepatitis 
C infection. The postcards are soon to be available in cafés 
nationwide. Antonia Leslie, journalist from the Sunday 
Independent, supported the event and presented members 
of Ban Óg in Tallaght and Youthreach on Pleasants Street 
with certifi cates for having completed a four-week health 
promotion course on HIV and hepatitis awareness.
(Davina Swan, researcher at UCD School of Medicine and 
Medical Science) 
For further information on hepatitis C please contact 01 - 
473 6615 or visit www.hepinfo.ie. 
World Hepatitis Day
Health promotion plan to address HIV
On 17 June 2008 Mary Wallace TD, Minister for Health 
Promotion and Food Safety, launched the HIV and AIDS 
Education and Prevention Plan 2008–2012, presented by the 
Education and Prevention Sub-Committee of the National 
AIDS Strategy Committee.1 
The Minister said that she was pleased to mark Irish 
AIDS Day (15 June) with the launch of this plan which 
demonstrates the commitment of all key stakeholders to 
continuing and enhanced efforts to prevent HIV and AIDS. 
The plan was developed over an 18-month period and 
was the result of a review of the evidence and a national 
consultation process.  It will build on the report of the 
National AIDS Strategy Committee (2000). Under six key 
action areas, the plan addresses the needs of seven high-risk 
population groups. Injecting drug users and prisoners are 
identifi ed as two such groups.
Injecting drug users
According to the authors, ‘injecting is an even more effective 
way of spreading HIV than sexual intercourse. In most 
developed countries, including Ireland, the second most 
common transmission route for HIV is among men and 
women who inject drugs.’ In 2006, 2,104 of the 4,992 cases 
entering treatment in Ireland had injected an illicit drug at 
some point in their lives, of whom 59% had shared injecting 
equipment. The proportion of injecting drug users who 
engage in prostitution is unknown.  
In 2004 the World Health Organization acknowledged that 
needle-exchange programmes (which include proactive 
outreach and sexual health interventions) are extremely 
effective in reducing HIV transmission among injecting drug 
users. 
The Plan recommends:
continued delivery of safer injecting and sex • 
messages through drug treatment services, drugs 
task force projects and relevant non-governmental 
organisations; 
actions to prevent drug users who do not currently • 
inject from starting to do so;
interventions to increase testing, screening and • 
treatment for HIV; and
completion of NACD research on sex work among • 
drug users. 
Dr Shay Keating of the Drug Treatment Centre Board 
and Dáire Ryan of Roche Products (Ireland) Limited
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Hepatitis B is a vaccine-preventable disease which is 
transmitted through contact with blood or body fl uids of an 
infected person. The main routes of transmission are mother-
to-baby, child-to-child, sexual contact and unsafe injections. 
The number of cases notifi ed to the Health Protection 
Surveillance Centre (HPSC) increased each year between 
1996 and 2005, and decreased by 7% (to 811) in 2006 
(Table 1). There were 863 cases in 2007, of whom 705 had a 
chronic infection, 52 had an acute infection and the disease 
status of 106 cases was unknown. The surveillance system 
has recorded risk factor data since 2004, but the number of 
cases notifi ed to the HPSC that include data on risk factors 
is low (although it had increased in 2007 when compared 
to 2005). In 2007 half (353) of all cases had risk factor data 
reported, of whom six (2%) reported injecting drug use as 
their main risk factor. The number of such cases remained 
consistently low between 2005 and 2007, indicating the 
effi ctiveness of routine administration of the hepatitis B 
vaccine. 
(Jean Long)
Hepatitis B surveillance: risk factor 
reporting in 2007
Prisoners 
According to the authors, ‘prisoners’ human rights must be 
respected under both national and international legislation. 
Prisoners need protection from contracting diseases and, if 
infected, from any form of discrimination. Efforts to prevent 
infections in prisons are benefi cial for inmates, staff and the 
wider public. Studies in the 1980s found indications that 
extensive HIV transmission could occur in prisons and had 
the potential to affect the wider community.’ It is accepted 
that the use of drugs in prisons increases the risk of blood-
borne infections. Although ‘prisoners may be injecting less 
frequently than when outside prison, each injection is far 
more risky due to the scarcity of injecting equipment and 
hence the greater prevalence of sharing syringes.’
The authors note that in order to protect prisoners from 
blood-borne viral infections, HIV and HCV preventative 
measures must be available in prisons. ‘Since the early 
1990s, community needle and syringe programmes within 
the prison system in Europe have been evaluated and found 
to reduce the spread of HIV among injecting drug users 
without increasing drug injecting.’ Other measures include 
the provision of appropriate broad-spectrum treatment 
interventions.
The Plan recommends:
delivery of HIV information to prisoners and staff;• 
provision of condoms to prisoners;• 
confi dential and comprehensive HIV testing for • 
prisoners who request it; and
review of current HIV and drug programmes with a • 
view to linking them with similar HSE programmes. 
(Jean Long)
1. Education and Prevention Sub-Committee of the 
National AIDS Strategy Committee (2008) HIV and 
AIDS education and prevention plan, 2008–2012. Dublin: 
Stationery Offi ce. 
Table 1 Number (%) of acute and chronic hepatitis B cases reported to the HPSC, by risk factor status, 2005–2007
Hepatitis B status
2005 2006 2007
Acute Chronic Unknown Acute Chronic Unknown Acute Chronic Unknown
n % n % n % n % n % n % n % n % n %
All cases
72 8.2 688 78.7 114 13.0 93 11.5 659 81.3 59 7.3 52 6.0 705 81.7 106 12.3
Cases with 
risk factor 
data 52 72.2 218 31.7 14 12.3 70 75.3 184 27.9 5 8.5 43 82.7 297 42.1 13 12.3
Of which:
Injecting 
drug users 0 0.0 3 1.4 1 7.1 0 0.0 4 2.2 1 20.0 1 2.3 5 1.7 0 0.0
Cases 
without 
risk factor 
data 20 27.8 470 68.3 100 87.7 23 24.7 475 72.1 54 91.5 9 17.3 408 57.9 93 87.7
Total 874 811 863
Source:  Unpublished data from the HPSC
World Hepatitis Day (continued)
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First reports of risk factors from 
hepatitis C surveillance
Table 2 Number and percentage of hepatitis C cases reported to the HPSC, by risk factor status, 2007
Hepatitis C
2007
Risk factor status n %
Total number of cases 1558
Cases with reported risk factor data   658 42.2
Of which:
Injecting drug users   496 75.3
Recipients of blood/blood products    34   5.2
Other risk factors    89  13.5
No known risk factor identifi ed by patient or doctor    39    5.9
Cases without reported risk factor data   900  57.8
Source:  Unpublished data from the HPSC
Table 1 Number of cases of hepatitis C and 
 age-standardised rates (ASR) per 100,000 
 population, 2004–2007 
Year Number of cases ASR
2004 1130 25.5
2005 1433 33.4
2006 1222 28.5
2007 1558 36.8
Source: Murphy and Thornton (2008)
Hepatitis C is one the most common blood-borne viral 
infections among injecting drug users and is transmitted 
through contact with the blood of an infected person. The 
main routes of transmission are mother-to-baby, unsafe 
injections, transfusion of blood and blood products, and 
unsterile tattooing and skin piercing. Murphy and Thornton 
reported that 1,558 cases of hepatitis C were recorded by 
the Health Protection surveillance Centre (HPSC) in 2007 
(Table 1), compared to 1,130 cases in 2004, and 85 cases of 
hepatitis ‘type unspecifi ed’ in 2003.1 
Of the cases reported in 2007, 77% were notifi ed by 
services in Dublin, Kildare and Wicklow and the remainder 
by services in HSE areas outside these counties. The authors 
calculated age-standardised hepatitis C rates per 100,000 of 
the population living in each former health board area for 
the years 2004 to 2007. The rate increased in all of those 
areas in 2007 compared to 2004, and was highest in the 
east (over 70 per 100,000) and lowest in the north west (at 
10 per 100,000). Sixty-three per cent of hepatitis C cases 
reported were male. Of the cases for whom age was known, 
92% were aged between 20 and 54 years. 
An enhanced surveillance system for hepatitis C was 
introduced in Ireland in 2007. Enhanced surveillance is 
essential to identify risk factors and for planning prevention 
and treatment strategies. In 2007, 42% of newly reported 
hepatitis C cases had their risk factor status recorded (Table 
2) (N Murphy, HPSC, personal communication, 2008). As 
expected, the majority of these cases (75.3%) reported 
injecting drug use as the main risk factor. Just over 5% of 
cases reported that they had been recipients of blood or 
blood products at some time in the past and, according to 
the HPSC, were late reports to the system. 
Data from blood-borne viral prevalence studies between 
1995 and 2005 indicate that around 70% of injecting drug 
users attending drug treatment tested positive for antibodies 
to the hepatitis C virus.2 Injecting practices and prison 
history were associated with hepatitis C status in some of 
these studies. 
The National Immunisation Advisory Committee and 
the Department of Health and Children recommended 
signifi cant changes to Ireland’s national childhood 
immunisation programme in 2008.3 These changes, 
published in the revised Immunisation guidelines for 
Ireland in July 2008,4 include the addition of a hepatitis 
B vaccine to the routine 5-in-1 childhood immunisation 
programme, which will now become a 6-in-1 programme. 
The Immunisation guidelines for Ireland 2002 recommended 
the hepatitis B vaccine for several high-risk groups only, 
including prisoners and injecting drug users, rather than for 
the child population. 
(Jean Long)
1. Murphy N and Thornton L (2008) Epidemiology of 
hepatitis C infection in Ireland. EPI-Insight, 9(7): 2–3.
2. Long (2006) Blood-borne viral infections among injecting 
drug users in Ireland, 1995 to 2005. HRB Overview Series 
4. Dublin: Health Research Board.
3. Cotter S (2008) Changes to the Irish primary childhood 
immunisation programme. EPI- Insight, 9(8): 1. 
4. National Immunisation Advisory Committee (2008) 
Immunisation guidelines for Ireland. 2008 edition. Dublin: 
Royal College of Physicians of Ireland.
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Identifying new drugs and new drug 
trends with the help of drug helplines
In May 2008 the European Foundation of Drug Helplines 
(FESAT) published the results from its twelfth monitoring 
project.1 Since the beginning of 2001 FESAT has been 
collecting information every six months on the types of 
person contacting helplines, the content of these calls 
and how this has changed compared to the previous six 
months. According to the author, the main objective of this 
monitoring is to identify early the emergence of new drugs 
and new drug trends; the data collected cannot quantify 
the size of any change. Of the 31 relevant FESAT helplines, 
20 helplines in 13 European countries, including Ireland, 
participated in the project. This article will describe some of 
the main changes that were reported by the helplines during 
the fi rst half of 2007.
The smallest of the 20 participating helplines answered an 
average of one call per day, and the largest, 121 calls. Four 
helplines answered fi ve or fewer calls per day, 13 helplines 
answered between fi ve and 20 calls per day, and three 
helplines answered 21 or more calls per day. The Drugs/HIV 
Helpline in Ireland answered an average of 15 calls per day, 
though this fi gure included calls about sexual health. There 
were 1,905 calls between January and June 2007.2 Some 
European helplines provide services by email as well as by 
phone, which makes their advice more accessible; the Irish 
helpline does not have this facility.
The FESAT report notes a continuation of the upward trend 
in the number of calls about cannabis (6 helplines) and 
about cocaine (6 helplines). The number of calls about 
alcohol also increased. The numbers of calls about injecting 
heroin and about ecstasy decreased. 
The Irish Drugs/HIV Helpline reported a large increase in 
the number of calls about intravenous heroin use in the fi rst 
half of 2007 compared with the second half of 2006. There 
was also a large increase in the number of calls referring to 
benzodiazepines. There was some increase in the number of 
calls referring to cannabis and certain opiates (methadone, 
Subutex, codeine and DF118). There was no signifi cant 
change in the number of calls referring to cocaine. Calls 
from male drug users aged between 20 and 25 years, and 
from parents or guardians, increased considerably during the 
fi rst half of 2007. The number of calls referring to alcohol 
decreased. 
Three helplines received calls about drugs that had not been 
reported to them before. A helpline in Norway reported 
a call about a substance called Polarmine, which is an 
antihistamine with sedative effects. The helpline in Belgium 
reported calls about LSA, or morning glory, which has 
hallucinogenic effects. The German helpline reported calls 
about fentanyl, which is a synthetic opiate. The Drugs/HIV 
Helpline in Ireland did not report any calls about new drugs 
during this period. 
(Jean Long)
1. Hibell B (2008) FESAT Monitoring Project- Changes during 
the fi rst half of 2007. Brussels: FESAT (The European 
Foundation of Drug Helplines). 
2. Aileen Dooley provided the author with data from the 
Drugs/HIV Helpline in Ireland. 
More information about FESAT can be found at 
www.fesat.org
The Drugs/HIV Helpline in Ireland is a confi dential, 
freephone, active listening service offering non-
directive support, information, guidance and referral 
to anyone with a question or concern related to 
substance use or HIV and sexual health. In its 11 years, 
the helpline has dealt with over 48,000 calls, and it 
offered information on over 300 relevant services 
nationwide. The freephone number is 1800 459 459. 
The Helpline manager is Aileen Dooley (a FESAT 
board member). 
HRB overview of suicide in Ireland
This publication, the seventh in the HRB Overview Series, 
looks at the rates of self-harm and suicide in Ireland from 
1864 to 2006, discusses possible motives for suicide and 
reviews prevention measures.1 
The author notes that suicide in Ireland has been greatly 
under-reported in the past, and that the recorded rate 
fl uctuated widely in the period under review. The rate 
increased steadily between 1968 and 1989, and then 
accelerated to a peak in 1998, followed by a slow decline 
between 2001 and 2006.
According to the report, the incidence of suicide among 
Irish males is three to four times greater than that among 
females; this fi nding is in line with international research. 
Signifi cant mental illness is a factor in a proportion of 
suicides. Alcohol consumption was found to have a link 
to suicide, with European research showing that as many 
as one in six suicides are alcohol-related.2 The author of 
this overview suggests that the control of alcohol-related 
problems may be the only evidence-based approach to the 
prevention of suicide and self-harm.
The overview may be downloaded from the publications 
section of the HRB website at www.hrb.ie/publications. To 
request a hard copy of the report, email Fiona Bannon at 
fbannon@hrb.ie or phone +353 1 2345148. 
(Simone Walsh and Suzi Lyons)
1. Walsh D (2008) Suicide, attempted suicide and prevention 
in Ireland and elsewhere. HRB Overview Series 7. Dublin: 
Health Research Board. 
2. Anderson P and Baumberg B (2006) Alcohol in Europe. 
London: Institute of Alcohol Studies. 
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EU civil society forum discusses new EU 
action plan on drugs 
On 20–21 May 2008 the Civil Society Forum on Drugs in 
the European Union assembled in Brussels for its second 
meeting.1 Its purpose was to give constructive feedback to 
the European Commission for the new EU Action Plan on 
Drugs 2009–2012.2 
The key points to emerge from the two-day session, as 
summarised in the fi nal report, were:
EU drug policy must be based on the principles of  ■
public health and human rights. The principles of 
non-stigmatisation and non-discrimination need to be 
emphasised.
Co-ordination between civil society, EU institutions and  ■
member states should be strengthened and encouraged.
Specifi c attention should be paid to the needs of  ■
particularly vulnerable groups, gender differences, 
parents, youth and adolescents, migrants, ethnic 
minorities and drug users.
The new action plan should promote the development  ■
of quality standards in demand reduction, including 
prevention, treatment, harm reduction and social 
rehabilitation and reintegration.
The quantity and quality of data collection should be  ■
improved.
Responses to polydrug use need to be strengthened and  ■
the links between drugs, alcohol and prescription drugs 
should be further explored.
The action plan should pay attention to the relationship  ■
between drug use and mental health problems.
In co-operation with third countries, the new action plan  ■
should advocate alternative development, while taking 
into account poverty and social deprivation. 
The action plan should try to improve the situation in  ■
prisons, important places for prevention, education and 
rehabilitation programmes, and the support to drug 
users after release from prison.
Efforts should be made to reduce drug-related deaths by  ■
making available treatment or harm reduction services.
Coverage of, access to and effectiveness of drug demand  ■
reduction measures should be improved.
Substitution programmes should be made more effective  ■
and integrated with other programmes.
In conclusion, the report outlined the steps to be taken 
to fi nalise the action plan. The European Commission will 
publish a draft EU action plan on drugs 2009–2012 in 
the third week of September. This document will go to 
the European Council, where it will be discussed by the 
Horizontal Drugs Group. By the end of the year the plan 
should be adopted and should be part of the conclusions 
of the European Council. The next civil society forum will 
probably be held in 2009. 
(Brigid Pike)
1. Directorate-General Freedom Security and Justice (2008) 
Civil society forum on drugs in the European Union, Brussels, 
20–21 May 2008, Final Report. Retrieved on 21 August 
2008 from http://ec.europa.eu/justice_home/fsj/drugs/
forum/docs/fi nal_report_2008_en.pdf. For an account of 
the fi rst meeting of the forum, see Randall N (2008) EU 
civil society forum on drugs. Drugnet Ireland, (25): 24.
2. The fi nal report on the meeting states: ‘The current EU 
Treaty gives the Commission only a limited formal legal 
basis on drug policy and its chief role is to represent 
and defend the European interest. The Commission 
works through consensus building and consultation, 
acting mainly as a facilitator between member states. 
Civil society representatives have direct knowledge of 
the reality in their countries and they can provide the 
Commission with realistic and useful expertise to feed 
into the work on the new Action Plan on Drugs 2009–
2012’ (p. 4). 
Understanding drug-related public 
expenditure 
In July 2008 the European Monitoring Centre for Drugs and 
Drug Addiction (EMCDDA) published a report Towards a 
better understanding of drug-related public expenditure in 
Europe.1 It reports on a study undertaken by the EMCDDA 
in conjunction with 23 member states, including Ireland, in 
pursuit of the aim in the EU drugs action plan 2005–2008 
to produce estimates of public expenditure on drug-related 
issues.2 The study tested a methodology that would facilitate 
the collection and comparison of drug-related expenditure 
across jurisdictions with different political structures and 
government accounting systems. 
Why is understanding drug-related public expenditure 
important?
‘Quantifying a government’s drug-related expenditure is 
a fi rst step in formulating an economic evaluation of drug 
policy interventions. This will provide information that can 
be used to determine whether or not intended benefi ts 
are being achieved. Once developed, a standardised 
classifi cation system for this exercise will provide a useful 
framework for both policy decision-making and public 
administration accountability.’ (EMCDDA 2008: p. 11)
The study found that, in general, member states have 
a considerable amount of information on drug-related 
expenditure. It estimated that the total drug-related 
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Drug-related expenditure (continued)
public expenditure in Europe in 2005 (the year chosen for 
investigation) was around €34 billion, which was equivalent 
to 0.3% of the sum of the GDP of all the countries 
participating in the study. This meant that on average, for 
each million euro of a European country’s GDP in 2005, 
€3,000 were publicly spent on drug-related matters. This 
represented an average expenditure of €60 per European 
citizen per year. 
These fi gures are indicative only. Budget lines on drug-
related issues in member states are still too generic, too 
aggregated, over-inclusive, or simply unidentifi able. The 
methodological challenge for the EMCDDA was to develop 
a unifi ed and common classifi cation approach that would 
maximise the validity and comparability of results across 
countries. Two approaches were used – labelled and non-
labelled expenditure.3
Labelled expenditure
Labelled expenditure is the planned ex-ante expenditure 
that refl ects the voluntary commitment of the state in the 
fi eld of drugs. It can be traced back by a detailed review of 
budget and/or fi scal year-end accountancy reports. Ireland 
emerged as the country with the highest proportion of 
labelled expenditure (€176.8 million, i.e. 0.32% of total 
public expenditure). However, the authors noted a diffi culty 
with the Irish data in that only a small amount was recorded 
in public accountability documents:‘… details of only 
around 18% of labelled expenditure are published [i.e. the 
Drugs Initiative under Vote Community, Rural and Gaeltacht 
Affairs, and an allocation for drug-related housing measures 
under Vote Environment, Heritage and Local Government]. 
The remaining 82% is either subsumed under, but clearly 
identifi able in, some larger published budget, or it is a clearly 
defi ned drug-related programme or activity that receives 
funding from a range of different labelled budgets. Many 
departments and agencies involved in drug-related matters 
do not currently have adequate reporting systems in place to 
capture and report this budgetary complexity. However, the 
data is potentially available, particularly in relation to direct 
expenditure by government bodies.’ (pp. 12–13) 
The authors noted a further diffi culty in that there was 
no record of regionally- or locally-funded drug-related 
expenditure in Ireland. Funds were voted at national level 
and allocated by central departments and agencies for use 
at regional and local level. The authors commented: ‘As 
this type of expenditure represents a signifi cant portion of 
drug-related expenditure in Ireland, the issue needs to be 
addressed. One solution might be to record the expenditure 
according to both government and non-government 
activities, but the risk of double-counting would need to be 
managed.’ (p. 14)
Non-labelled expenditure
Non-labelled expenditure is the non-planned ex-post public 
expenditure faced by the general government in tackling the 
drugs issue. The study used a top-down, or gross costing, 
approach to estimating these expenditures. Starting from 
overall aggregated expenditures, participating countries 
were invited to estimate the proportion causally attributable 
to drug use (Non-labelled Drug-related Expenditure = 
Overall Expenditure x Attributable Proportion). For example, 
to estimate the prison drug-related expenditures in a given 
country, two elements were necessary: the overall prison 
expenditure in the country, for a given fi scal year, and the 
proportion of inmates in prison because of drug-related 
issues. The product of the two gives a rough estimate that 
could be compared across different countries. 
Only nine countries attempted this part of the study; Ireland 
did not participate as there was insuffi cient data. However, 
the fi ndings underline the importance of attempting to 
estimate this type of spending. In comparing the fi ndings 
on labelled and non-labelled expenditures on health and on 
public order and safety, the authors reported that labelled 
expenditure on health exceeded that on public order and 
safety, whereas non-labelled estimations suggested that 
public order and safety spending exceeded that on health. 
The authors concluded: 
… despite public order and safety functions attaining 
higher levels of expenditure than health functions, health 
expenditure is more present in accountancy documents. 
Thus it can be said that, in general, health expenditure 
on drug-related issues is more distinct than expenditure 
allocated to law enforcement issues. Although this can 
easily be explained by the fact that expenditure on public 
order and safety tends to be embedded in broader and 
more general programmes of action against crime, one 
must remember that an assessment of the effi ciency of 
government action is not feasible without a clear and 
well-defi ned formulation and classifi cation of expenditure, 
where costs are properly identifi ed in the relevant budget 
appropriations. The budget is the fi nancial mirror of 
government policy; if the budget excludes important 
expenditure, there can be no assurance that scarce resources 
are allocated to priority programmes and that proper control 
and public accountability are enforced. (p. 23) 
The authors concluded that the twofold methodology 
proposed and implemented by the EMCDDA, although 
preliminary, had proved to be ‘feasible and scientifi cally 
robust’ and called for the work to continue. 
(Brigid Pike)
1. European Monitoring Centre for Drugs and Drug 
Addiction (2008) Towards a better understanding of 
drug-related public expenditure in Europe. Selected issue. 
Lisbon: Offi ce for Offi cial Publications of the European 
Communities.
2. In Ireland, the Alcohol and Drug Research Unit (ADRU) of 
the HRB, the Irish national focal point of the EMCDDA, 
undertook the necessary data-collection and reporting 
work. The report on the Irish fi ndings is available in 
the National Report 2007 at www.ndc.hrb.ie/ebooks.
php?msel=4 
3. This article describes the data-collection and validation 
methodology that was tested. It does not discuss the 
approaches that were used to compare expenditures 
across countries; these approaches included classifying 
expenditures by governmental function and by drug 
programme.
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Drug policy priorities during the 
French EU Presidency
In the work programme for its six-month EU 
Presidency, between 1 July and 31 December 2008, 
the French Presidency states with regard to illicit 
drugs that, within the context of making Europe 
safer for its citizens:
… it will be the task of the French 
Presidency, on the basis of a proposal 
by the Commission, to bring work on a 
new EU action plan for the 2009–2012 
period to completion. On actions aimed at 
countries or regions particularly affected 
by trafﬁ cking in narcotics or chemical 
precursors, it will pay special attention 
to the Western Mediterranean, where 
it will propose the creation of an Anti-
drugs Coordination Centre, to be known 
as CECLAD-M. Arrangements for a closer 
dialogue with Western Africa, which has 
become a signiﬁ cant transit region for 
cocaine from South America, will also be 
explored. 1
Under the heading ‘Commitment to youth’, the 
French Presidency states that it will also pay ‘special 
attention … to the problem of addiction among 
young people’.
The website of the French government’s inter-
ministerial mission against drugs (MILDT) identifi es 
two priorities in the drugs area during the French 
Presidency: (1) facilitating the negotiation of the 
new EU drugs action plan, and (2) preparing a 
unifi ed EU position for the next session of the 
Commission on Narcotic Drugs (CND) in Vienna in 
March 2009, when the international approach to 
the drugs issue to succeed the UN’s 10-year action 
plan 1998–2008, will be worked out. In pursuing 
these objectives, it hopes to strengthen co-
operation with third-world countries in combating 
drugs, and to explore how to enhance the impact 
of drug policies and to increase public awareness of 
the policies.2
In line with its two priorities the French government 
has identifi ed three goals: 
to strengthen the stature and political • 
authority of the Horizontal Drugs Group 
(HDG), in line with the expectations set out 
in the EU Dugs Strategy 2005–2012;3 
to produce an EU drugs action plan 2009–• 
2012 that will have a demonstrable impact 
across EU member states; and 
to have an agreed EU position at the CND • 
session in Vienna in March 2008 that will 
add value both to Europe’s and to the 
international community’s drug policies
With regard to the HDG and the new action plan, 
the French will consider the following approaches:
undertaking a shared analysis on the state of • 
the drugs threat 
simplifying and narrowing the focus of the • 
new drugs action plan
strengthening the judicial component of • 
drug control co-operation between member 
states and other countries
strengthening systems for identifi cation, • 
confi scation, and sharing information on 
known criminals
reviewing the HDG with a view to including • 
alcohol within its purview
better informing the public about drugs • 
studying means of spreading primary • 
prevention messages to young people using 
new media
With regard to external relations, the French 
will seek dialogue with traditional and with new 
partners. The focus of these dialogues will be on 
strengthening the profi le of the drug problem in 
Europe and improving the effectiveness of joint 
actions. 
(Brigid Pike)
1. French Presidency of the Council of the 
European Union (2008) Work programme 
1 July–31 December 2008. Retrieved on 19 
August 2008 at www.ue2008.fr 
2. This account is based on the information 
provided on the website of the Mission 
Interministerielle de Lutte Contre la Drogue et 
la Toxicomanie (MILDT) at www.drogues.gouv.
fr. The information was retrieved on 19 August 
2008. A literal translation in to English of the 
information is available on the website of the 
International Drug Policy Consortium www.
idpc.info. This translation was also retrieved on 
19 August 2008.
3. The Horizontal Drugs Group (HDG) is the EU 
Council’s main technical and policy forum 
to facilitate joint efforts between member 
states and the European Commission. It 
meets about once a month, bringing together 
representatives from member states and the 
Commission, with a view to analysing, taking 
measures on and seeking to co-ordinate the 
drug-related activities of the EU. 
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International Harm Reduction 
Association 2008 conference 
The International Harm Reduction Association 
(IHRA) 19th international conference took place 
on 11–15 May 2008 in Barcelona, Spain. The IHRA 
promotes evidence-based harm reduction policies 
and practices on a global basis for all psychoactive 
substances (including illicit drugs, tobacco and 
alcohol). 
The conference was attended by 1,280 people from 
some 80 countries. The programme included the 
screening of 30 fi lm documentaries from around 
the world as part of the 5th International Drugs and 
Harm Reduction Film Festival, which was hosted by 
the conference. At the opening session, the IHRA 
launched the fi rst in a series of major publications 
from its new HR2 (Human Rights and Harm 
Reduction) programme.1
The conference theme was to promote a global 
approach to the policy and practice of harm 
reduction. The IHRA executive director, Dr Gerry 
Stimson, addressed this topic in a plenary session 
and reported that 82 countries currently support 
or tolerate harm reduction responses; 77 operate 
needle- and syringe-exchange services and 63 
provide opioid substitution treatment. He said that, 
despite these advances, obstacles remain to the 
universal implementation of harm reduction, such 
as the adoption by countries of a ‘war on drugs’. 
He stressed the need for a global approach to 
increasing the coverage of harm reduction services.
Acknowledging that most harm reduction 
interventions target opiate-injecting drug use, 
Dr Stimson pointed to the need for improved 
interventions to reduce the harm associated with 
the use of other drugs (including alcohol and 
tobacco). 
The conference programme offered a wide range of 
experiences and evidence from around the world. 
The Irish researcher Paula Mayock spoke about an 
ethno-epidemiological approach to understanding 
and reducing drug-related harm, as used in her 
study on the initiation of heroin use among 
high-risk youth in Ireland. Mayock reported three 
pathways to initiation: criminal careers, intimate 
relationships, and homelessness.2 
Log onto www.ihra.net to view the list of abstracts 
and presentations from this conference. The 
20th IHRA conference will take place in Bangkok, 
Thailand, on April 19–23 2009. The conference 
theme will be ‘Harm reduction and human rights’. 
(Janet Robinson)
1. Cook C and Kanaef N (2008) The global state 
of harm reduction 2008: mapping the response 
to drug-related HIV and hepatitis C epidemics. 
London: International Harm Reduction 
Association. 
2. Mayock P (2002) Drug pathways, transitions 
and decisions: the experiences of young 
people in an inner-city Dublin community. 
Contemporary Drug Problems, 29(1): 117–156. 
Film launch by RADE group
RADE (recovery through art, drama and education) 
was established in August 2004 as an innovative 
programme for recovering drug users. Its purpose 
is to help participants ‘fi nd a path forward into 
personal development and education through 
participation in the arts’.
Raders of the Tain, a documentary fi lm and book 
by RADE was launched by Cllr Dermot Lacey, 
Chairperson of South West Inner City Local Drugs 
Task Force, as part of Dublin Culture Night on 
Friday 19 September in the Irish Film Institute, 
Temple Bar. The documentary illustrates how the 
RADE scheme works to develop, motivate and 
guide participants through recovery. 
26
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In brief
On 19 May 2008 the Archways National Conference on 
the Incredible Years Programme was held in Dublin. The 
programme is designed to prevent and treat emotional 
and behavioural diffi culties in children aged 3–10 years. It 
is being rolled out in Ireland and evaluated by Archways, 
which promotes and researches evidence-based programmes 
as interventions for such young people. The Minister for 
Children, Barry Andrews TD, who opened the conference, 
said: ‘The Government and HSE are committed to 
rebalancing child welfare services towards early intervention 
and family support measures. Working with children within 
their own families and communities is in the best interests 
of children and is an important factor in ensuring that they 
reach their full potential’. www.archways.ie 
In June 2008 Eurostat, the Statistical Offi ce of the European 
Communities, issued fi gures on household expenditures, 
based on the 2005 Household Budget Survey in the 27 
member states. The data show that, at 4.1%, household 
expenditure on alcoholic beverages in Ireland in 2005 was 
the highest in the EU. The mean EU27 level was 1.2%. 
It should be noted that the relative level of expenditure 
in each member state does not simply refl ect the level of 
consumption, but also price levels and the overall level of 
household expenditure. http://ec.europa.eu/eurostat 
On 5 June 2008 Alcohol and the Emergency Department 
– making the difference, a new training resource for 
emergency department staff and the fi rst of its kind to 
be developed in Ireland, was launched in Cork University 
Hospital. Developed by the HSE South’s emergency 
department, liaison psychiatry and health promotion staff, 
the training DVD and associated posters and booklet have 
been produced to encourage emergency department staff 
to safely and supportively raise the issue of alcohol use with 
patients admitted with an alcohol-related injury or illness. 
www.hse.ie 
On 23 June 2008 the Drug Policy Action Group (DPAG) 
published the third in its series of policy papers, entitled 
Key issues for drugs policy in Irish prisons. Author Paul 
O’Mahony concludes his analysis of the issues with a list 
of things that should happen ‘in order to achieve a more 
rational, effective and rehabilitative prison system’. They 
include adjusting current sentencing policy and reducing the 
number of minor, non-violent, drug-using offenders being 
sent to prison for short terms, and an increased use of the 
Drug Court; mandatory drug treatment outside prison and 
non-custodial sanctions; less emphasis on supply control 
in prisons and more on reducing the harms caused to 
prisoners by the current drugs culture in prisons; a greater 
focus on abstinence-based treatments than on methadone 
substitution; and improved prison conditions and provision 
of an environment conducive to the general rehabilitation of 
offenders. www.drugpolicy.ie 
On 26 June 2008, International day against drug abuse 
and illicit traffi cking, the UN Secretary-General, Ban Ki-
Moon, issued the following message: ‘We still have much 
work to do to reduce our vulnerability to drugs. States with 
weak criminal justice systems and limited law enforcement 
capabilities need assistance to reduce illicit drug traffi cking, 
which spreads crime, corruption and instability, and 
which ultimately endangers the successful realization of 
the Millennium Development Goals. As we mark the 60th 
anniversary of the Universal Declaration of Human Rights, 
I remind all Member States of their responsibility to fully 
respect the rights of prisoners who are drug dependent or 
are in custody for drug-related crimes, especially their rights 
to life and a fair trial. I also call on Member States to ensure 
that people who are struggling with drug addiction be given 
equal access to health and social services. No one should 
be stigmatized or discriminated against because of their 
dependence on drugs.’ www.unodc.org
On 26 June 2008 the World drug report 2008, compiled by 
the United Nations Offi ce on Drugs and Crime (UNODC), 
was published. This annual publication provides detailed 
estimates and trends on production, traffi cking and 
consumption in the opium/heroin, coca/cocaine, cannabis 
and amphetamine-type stimulants markets. This year’s 
edition reports that ‘the drug problem is being contained 
but there are warning signs that the stabilisation which has 
occurred over the last few years could be in danger. Notable 
amongst these is the increase in both opium poppy and 
coca cultivation in 2007, some growth in consumption 
in developing countries and some development of new 
traffi cking patterns. There have also been encouraging 
contractions in some of the main consumer markets.’ This 
year, almost one hundred years since the Shanghai Opium 
Commission in 1909, the report also gives a historical review 
of the development of the international drug control system. 
www.unodc.org 
On 26 June 2008 the European Monitoring Centre 
for Drugs and Drug Addiction (EMCDDA) released A 
cannabis reader: global issues and local experiences — 
perspectives on cannabis controversies, treatment and 
regulation in Europe. Leading European experts provide 
informed insight into a wide range of cannabis topics, from 
political, legislative, economic and social developments to 
prevention, treatment and healthcare. 
www.emcdda.europa.eu 
On 30 July 2008 the UK Drug Policy Commission published 
Tackling drug markets and distribution networks in the 
UK: a review of the recent literature. This review found 
that UK drug markets are extremely resilient and increasing 
drug seizures have had little street-level impact. Despite 
hundreds of millions of pounds spent each year on UK drug 
enforcement activity, there is remarkably little evidence of its 
effectiveness in disrupting markets and reducing availability. 
The available evidence supports a local partnership approach 
that focuses on reducing the impact of drug markets as felt 
by communities. www.ukdpc.org 
(Compiled by Brigid Pike)
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From Drugnet Europe
Journal articles
The following abstracts are cited from recently published 
articles relating to the drug situation in Ireland.
Opiate-dependent adolescents in Ireland: a descriptive 
study at treatment entry
Fagan J, Naughton L and Smyth B 
Irish Journal of Psychological Medicine 2008; 25 (2): 46–51
The aim of this research is to describe the drug history 
and psycho-social problems among under-19s accessing 
treatment for opiate dependency, including methadone 
maintenance, and examine for any gender differences. A 
descriptive study of under-19s at the largest drug treatment 
clinic in Dublin was undertaken between October 2000 and 
September 2006. Data were gathered by reviewing case 
notes, assessment questionnaires and urine drug screens. 
In total, 86 young people were included. Their mean age 
was 16.8 years. Forty-six (54%) were female. Only 26 (30%) 
reported an intact family of origin. Twenty-three (27%) had 
spent time in care. Mean age for fi rst use of any illicit drug 
was 12.4 years, and for heroin was 14.8 years. The mean 
age of leaving school was 14.4 years; 42 (49%) fi rst tried 
heroin after leaving school. Forty-one (48%) had a history of 
homelessness. Forty-four (51%) had previously injected; 26 
(30%) were currently injecting. Fifty-six (65%) had not been 
screened for blood-borne diseases; 21 (24%) subsequently 
tested positive for hepatitis C. Thirty-eight (48%) had 
Recent publications
Drugnet Europe is the quarterly newsletter of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). 
Drugs in Focus is a series of policy briefi ngs published by the EMCDDA. Both publications are available at 
www.emcdda.europa.eu. 
If you would like a hard copy of the current or future issues of either publication, please contact: 
Alcohol and Drug Research Unit, Health Research Board, Knockmaun House, 42–47 Lower Mount Street, Dublin 2. 
Tel: 01 2345 127; Email: adru@hrb.ie
EMCDDA publishes cannabis reader 
Cited from Drugnet Europe No. 63, July–Sept 2008
On International day against drug abuse and illicit traffi cking  
the EMCDDA released its largest scientifi c monograph to 
date: A cannabis reader: global issues and local experiences 
– perspectives on cannabis controversies, treatment and 
regulation in Europe. In two volumes, and over 700 pages, 
leading European experts provide informed insight into a 
wide range of cannabis topics: from political, legislative, 
economic and social developments to prevention, treatment 
and healthcare. 
The monograph describes the concerns expressed, 
particularly at UN level, that a ‘soft line’ on cannabis could 
endanger the overall international effort against drugs. It 
also traces recent developments in some countries where 
the balance is ‘tipping back’ in favour of more restrictive 
measures.
For the monograph, summary and news release, see: www.
emcdda.europa.eu/events/2008/26june
New report on drug-related public expenditure
Article by Luis Prieto and Marie-Christine Ashby in Drugnet 
Europe No. 63, July–Sept 2008
Producing estimates of drug-related public expenditure is 
one of the many targets set by the current EU drugs action 
plan (2005–08). In this light, the EMCDDA launched in July 
its latest Selected issue publication focusing on Drug-related 
public expenditure in Europe.1 Testing a new methodology, 
combining ‘labelled’ and ‘unlabelled’ expenditure,2 the 
report presents preliminary estimates of how much European 
governments are spending on the drugs problem. While 
fi gures should be used with caution (methodology needs 
refi ning; data remain patchy), estimates from reporting 
countries, extrapolated to European level, arrive at a total 
cost of drug-related public expenditure in 2005 of EUR 34 
billion. This represents an average expenditure of EUR 60 per 
European citizen per year.
A considerable amount of quality information is available 
in Europe on drug-related public expenditure (mostly 
labelled). One observation made in the report is that 
the disbursements identifi ed so far mainly refer to public 
spending at central government level. The future inclusion 
of sub-national government expenditure on drugs would 
therefore certainly result in higher fi gures.
1. EMCDDA (2008) Towards a better understanding of 
drug-related public expenditure in Europe. Selected 
issue. Luxembourg: Offi ce for Offi cial Publications of 
the European Communities. Available online at www.
emcdda.europa.eu
2. ‘Labelled expenditure’ refers to planned spending, 
refl ecting a state’s voluntary commitment in the drugs 
fi eld. It can be traced by reviewing offi cial accountancy 
documents over a given period. ‘Unlabelled expenditure’ 
refers to unplanned spending and is estimated through 
modelling techniques. The twofold approach aims to 
provide more comprehensive and accurate estimates of 
public spending in tackling drugs and drug addiction 
Europe-wide. See Drugnet Europe No. 61.
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previous convictions; 33 (38%) were facing charges. Forty-
fi ve (52%) had previously seen a psychiatrist; nine (11%) 
had received inpatient psychiatric treatment. In terms of 
gender difference, boys were more likely to leave school 
early, have a substance-abusing sibling, and to have a past 
conviction. Girls were more likely to have a partner, and to 
have taken a deliberate overdose. 
This study highlights the complex and multiple needs of 
opiate-dependent teenagers. In order to meet their needs, 
services will require a broad range of interventions and 
excellent interagency co-operation.
Childhood adversity and substance misuse
Ambreen Taj A, Keenan E and Casey P 
Irish Journal of Psychological Medicine 2008; 25(1): 29–30
There is a strong link between childhood adversity and 
subsequent substance misuse. The authors describe a case of 
childhood adversity consisting of physical and sexual abuse, 
experience of homelessness in childhood and adulthood, 
intimate partner violence and polysubstance misuse in a 
32 year-old woman currently attending the methadone 
maintenance programme in the Drug Treatment Centre 
Board, Trinity Court, Dublin. Relevant literature is reviewed 
in relation to the aetiology and symptoms of this complex 
case.
Alcohol use and misuse in older people: a local 
prevalence study comparing English and Irish inner-city 
residents living in the UK
Rao R, Wolff K and Marshall E J 
Journal of Substance Use 2008; 13(1): 17–26
Alcohol consumption was assessed among Irish and English 
men and women aged 65 and over living in an inner-
city area of London, using Quantity/Frequency measures 
and validated questionnaires (SMAST-G, 10-item AUDIT, 
SF-36). Sixty subjects with a mean age of 77.5 years were 
recruited. English subjects showed greater changes between 
lifetime and last-year drinking patterns. Irish subjects had a 
signifi cantly higher mean AUDIT score and were signifi cantly 
more likely (14/30 vs. 3/30) to have a family psychiatric 
history. Irish subjects were more likely to drink at least once 
a week, showed a higher mean alcohol intake (6.4 vs. 2.4 g) 
over the previous year and were more likely to show binge 
drinking (8/30 vs. 1/30) and drinking above sensible limits 
(8/30 vs. 1/30). The main implication of the study is that 
closer attention is required in screening for alcohol use in 
older Irish men in the UK.
The normalisation of substance abuse among young 
Travellers in Ireland: implications for practice
Van Hout MC and Connor S 
Journal of Ethnicity in Substance Abuse 2008; 7(1): 5–21
The aim of this exploratory study was to assess the nature 
and extent of drug use among a group of 12–18-year-
old Travellers in the south east of Ireland. The results are 
intended to inform Irish policy by providing data on patterns 
of youth drug use, drug-related risk behaviours, the impact 
of drug use on the Traveller community and issues regarding 
access to services. In terms of drug use and attitudes, 
young Travellers demonstrated similar trends to ‘settled’ 
adolescents. However, they reported poor levels of health 
awareness and knowledge of drug services. The authors 
conclude that the social exclusion of young Travellers puts 
them at risk of problem drug use, due to issues of poor 
literacy levels, family crisis, discrimination, poor knowledge 
of service provision relating to drug education and 
treatment, and the location of halting sites in areas of high 
drug usage. 
The impact of opiate dependence on parenting 
processes: contextual, physiological and psychological 
factors
Hogan D 
Addiction Research & Theory 2007; 15(6): 617–635 
This article examines how dependence on opiates affects 
parenting capacity and family processes. The fi ndings are 
based on in-depth, semi-structured interviews with 100 
parents (50 drug-using [opiate dependent] and 50 non-
drug-using) living in Dublin. Qualitative analyses suggest 
that opiate dependence has a specifi c impact on parenting 
processes and particularly on the physical and emotional 
availability of parents and on parental capacity to provide 
an emotionally consistent environment. The implications for 
children’s development and well-being, and for support of 
affected families, are considered. The authors recommend 
further study on the implications of parental drug use for 
children’s well-being and development.
A community perspective of cocaine use in Ireland: A 
brief exploratory study
Van Hout MC 
Contemporary Drug Problems 2007; 34(1): 103–110
The aim of this exploratory research was to document 
perceptions of the extent of cocaine use in an inner-city 
community (of 4,000 households) in Ireland. The study 
was undertaken in response to community concern at an 
apparent increase in the availability of cocaine, increased 
cocaine use as social activity, and the destructive impact on 
both individual and community. Relevant individuals were 
interviewed, including: drug-service providers, An Garda 
Síochána, youth workers, drug counsellors, family-support 
workers, general practitioners, hospital personnel, night-
club owners, publicans, parents and carers, taxi drivers, 
doormen, community workers, money advice and lending 
services, outreach workers, prison liaison offi cers, politicians 
and a small number of key informants considered to have 
experience of and insight into common and preferred drug-
taking practices in the community. 
This research indicates an increased prevalence of polydrug 
cocaine use among groups of recreational drug and alcohol 
users, as well as polydrug use among those attending the 
methadone clinic. This represents a signifi cant challenge for 
drug education, prevention, and treatment services in this 
community.
(Compiled by Louise Farragher)
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(Compiled by Louise Farragher – lfarragher@hrb.ie)
October 
2–4 October 2008 
19th Annual Conference European Society for Social Drug 
Research
Venue:  Budapest, Hungary 
Organised by / Contact: Bernadette Kun, ESSD 
Tel: +36 1 237 6732 
Email: kun.bernadette@ndi-int.hu 
Information: Papers presented will address the following 
topics :
How to collect qualitative data•  
Innovative methodologies. Indigenous fi eldwork. 
Observational studies. Gaining access and gate 
keepers. Do’s and don’ts of snowball sampling.  
Trends and patterns in drug use•  
‘New’ drug trends, new users or ‘old’ drugs. 
Changing patterns of drug use and changing users’ 
profi les. Similarities and differences in drug use across 
Europe. Including new EU member states. 
Drug markets•  
Availability and access to drugs. How and where 
users get/buy drugs. The structure of drug dealing 
networks. The dynamics of drug traffi cking and drug 
control.
Attitudes and opinions•  
Risk perception. Reasons to use or not use drugs. 
Opinions about drug policy. Attitudes towards drugs 
and drug users in the general population and among 
professionals.
Theories and concepts•  
The meaning of theoretical concepts such as 
normalisation, marginalisation, harm reduction and 
demand reduction. Theory and concept analysis. 
6–8 October 2008 
11th International Symposium on Substance Abuse 
Treatment
Venue: Växjö University, Sweden 
Organised by / Contact: European Working Group on Drug 
Oriented Research (EWODOR) and European Federation of 
Therapeutic Communities (EFTC) 
Email: ylva.benderix@vxu.se 
www.vxu.se/iped/events/international_symposium 
Information: Attendees will explore the obstacles and 
possibilities of knowledge development within this fi eld. 
One aim is to gather both researchers and practitioners 
within the fi eld of substance abuse treatment in Europe. The 
conference will be hosted by The Institute for Development 
of Knowledge about Treatment of Substance Misuse (IKM) at 
Växjö University. The three themes of the symposium are: 
Knowledge for evidence – when and how?• 
Science – how to assure quality and cost • 
effectiveness?
Practitioners’ knowledge – how to make it visible? • 
13–15 October 2008 
The Fourth European Association of Addiction Therapy 
Conference
Venue: Convitto della Calza, Florence, Italy 
Organised by / Contact: European Association of Addiction 
Therapy (EAAT) 
Email: info@eaat.org 
ww.eaat.org
Information: EAAT was developed to create dynamic annual 
conferences covering all topics relating to addiction. EAAT 
provides a focus for understanding the scientifi c, medical 
and social bases of addiction, and a discussion forum to 
further develop relevant therapies throughout Europe. EAAT 
also provides a central platform through which information 
can be disseminated across country and cultural boundaries. 
EAAT 2007 was attended by over 400 people from nearly 
30 countries. The 2008 conference programme contains 
plenary lectures as well as a choice of interactive seminars. 
18 October 2008 
Getting it right – Alcohol and Drugs Prevention Education in 
Primary Schools: The Way Forward
Venue: Red Cow Moran Hotel, Dublin 
Organised by / Contact: Substance Misuse Prevention 
Programme (Walk Tall) and Dublin West Education Centre 
Tel: +353 1 452 8017 
Email: walktall@eircom.net 
www.walktall.ie
Information: This conference is open to primary school 
principals, SPHE co-ordinators, teachers and others with 
an interest in alcohol and drugs prevention within the 
context of the primary school curriculum. The registration 
form is available on the website. There is no charge for the 
conference, but it is advisable to book early as places are 
limited. Speakers include: 
Dr Harry Sumnall, Liverpool John Moores University• 
Dr Gregor Burkhart, European Monitoring Centre for • 
Drugs and Drug Addiction
Dr Mark Morgan, St Partick’s College, ESPAD• 
Jayne Simms & Deborah Trainor, Education and • 
Library Board, NI. 
Afternoon workshops include: 
Martin Keane, HRB 
The role of theory in planning drug education: unpacking 
contested assumptions that underpin your work in 
contemporary society 
Ruby Morrow, Psychologist 
How teachers can support children affected by alcoholism 
and drug addiction 
Esther Wolfe, HSE 
Alcohol, drugs and young people: infl uences, risk and 
protective factors
Mary Hough, SMPP 
Does alcohol and drugs prevention education raise child 
protection issues?
Ursula Smyth, SMPP 
Implementing the Walk Tall programme: key issues for 
teachers/schools
drugnet 
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18 October 2008 
Family Focused Drug Prevention 
Venue: Dublin Castle, Ireland 
Contact/Organiser: Bernie Mc Donnell, Community 
Awareness of Drugs (CAD) 
Contact the CAD offi ce for invitation 
Tel: +353 1 679 2681 
Email: bmcdonnell@cadaboutdrugs.ie 
www.cadaboutdrugs.ie 
Information: This event is a CAD 25th anniversary update 
day for parents and guests. 
23 October 2008 
Fresh Challenges 
Venue: Purcell House Conference Centre, All Hallows 
College, Dublin 
Contact/Organiser: Bernie Mc Donnell, Community 
Awareness of Drugs (CAD). 
Download the registration from the CAD website. 
Tel: +353 1 679 2681 
Email: bmcdonnell@cadaboutdrugs.ie 
www.cadaboutdrugs.ie  
Information: This event is a CAD 25th anniversary education 
day for community workers. 
27–28 October 2008 
2008 National Conference on Injecting Drug Use
Venue: Novotel London West, Hammersmith 
Organised by / Contact: Exchange Supplies 
Tel: +44 (0)1305 262244 
Email: info@exchangesupplies.org 
www.exchangesupplies.org 
Information: A packed and varied programme with over 30 
parallel sessions, meetings, poster presentations and fi lms 
to inform practice, disseminate research, explore policy and 
develop skills. Conference highlights:
The launch of the 2008 ‘shooting up’ report• 
Draft NICE guidance – what it said, how you • 
responded
Promoting the transition from injecting to smoking• 
Injecting-related bacterial infections• 
TB and blood-borne viruses• 
Speedball injecting• 
Teaching people to access veins – practical issues• 
The injecting of human growth hormone (HGH) • 
explained
November
13–14 November 2008
Society for the Study of Addiction Annual Symposium 2008: 
Addiction Across the Lifespan
Venue: Park Inn, York, UK 
Organised by / Contact: Society for the Study of Addiction 
www.addiction-ssa.org 
Information: Symposium session themes include: addiction 
– routes in, routes out; natural recovery and self-change; 
wider impacts; and outcomes. In a special parallel session, 
Tom Babor will speak on Alcohol and Public Policy: A Report 
on the 2nd Edition of Alcohol: No Ordinary Commodity, 
covering:
Recent epidemiological research in alcohol policy• 
The role of the alcoholic beverage industry in alcohol • 
problems and public policy
Recent developments in intervention research: • 
including pricing and taxation, regulating physical 
availability, drink-driving countermeasures, regulation 
of alcohol promotion, treatment and prevention/
education
New effectiveness ratings for alcohol-related • 
intervention
16–20 November 2008
International Society of Addiction Medicine. 10th Annual 
Meeting
Venue: Westin Grand, Cape Town, South Africa 
Organised by / Contact: International Society of Addiction 
Medicine 
www.isam2008.com 
Information: The theme of the 10th ISAM Annual Scientifi c 
meeting is ’Understanding Addictions and Providing 
Comprehensive Care‘. The theme is resonant with the 
need to provide knowledge to those affected by addictions 
and to make care accessible to all who need it. ISAM, in 
collaboration with national and international organisations, 
hopes to make this meeting a memorable experience in 
terms of delivering evidence-based information on how 
to manage addictive disorders, how to plan community 
and hospital services, and how to promote advocacy 
for education and skills development in management of 
substance abuse and other addictions.
21 November 2008
Protecting Young People, Families and Communities: 
Evidence Based Responses to the New Drugs Strategy
Venue: Holiday Inn, Liverpool, United Kingdom 
Organised by / Contact: Centre for Public Health, Liverpool 
John Moores University 
Email: l.wilkinson@ljmu.ac.uk 
www.drugpreventionevidence.info/web/Conferences248.asp 
Information: With the introduction of the new UK National 
Drugs Strategy and Action Plan (Drugs: protecting families 
and communities) the Government has emphasised the 
importance of providing timely support for young people, 
families, and their communities. Increasingly, emphasis is 
placed on evidence-based approaches, although developing 
and delivering interventions based on research is diffi cult. 
This is particularly challenging when faced with a range 
of evidence from different disciplines and of different 
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The Alcohol and Drug Research Unit (ADRU) of the Health Research Board is a multi-
disciplinary team of researchers and information specialists who provide objective, reliable 
and comparable information on the drug and alcohol situation, its consequences and 
responses in Ireland. 
The ADRU maintains two national drug-related surveillance systems and is the national 
focal point for the European Monitoring Centre for Drugs and Drug Addiction. The unit also 
manages the National Documentation Centre on Drug Use. 
The ADRU disseminates research fi ndings, information and news through its quarterly 
newsletter, Drugnet Ireland, and the HRB series publications. Through its activities, the ADRU 
aims to inform policy and practice in relation to drug and alcohol use.
Drugnet Ireland is published by:
Alcohol and Drug Research Unit
Health Research Board
Knockmaun House
42–47 Lower Mount Street
Dublin 2
Tel: + 353 1 2345 127
Email: adru@hrb.ie
Managing editor: Brian Galvin
Editor: Joan Moore
quality. This conference will present the latest 
evidence and understanding on a range of 
young people’s substance use issues. It will 
present policy discussions, examples from 
practice, theory-driven interventions, and wider 
discussions of the role of substance use in young 
people’s lives today.
March 2009
2–3 March 2009
Third Annual Conference of the International 
Society for the Study of Drug Policy
Venue: Vienna, Austria 
Organised by / Contact: International Society 
for the Study of Drug Policy (ISSDP) 
Email: enquiries@issdp.org 
www.issdp.org 
Information: The third annual conference 
of the ISSDP will be hosted by the United 
Nations Offi ce on Drugs and Crime. Researchers 
interested in contributing papers that advance 
analysis of any aspect of drug policy are invited 
to submit abstracts to the conference organisers. 
The conference will be of interest to a wide 
array of disciplines including anthropology, 
economics, epidemiology, political science, 
public health and sociology. Participants in 
previous conferences have come from a variety 
of institutional backgrounds: universities, 
national and international agencies active 
in drug policy and independent research 
institutions. Practitioners who consider 
themselves consumers rather than producers 
of policy-relevant research should also fi nd the 
conference of interest; they will be particularly 
welcome as discussants of papers at each 
session.
25–27 March 2009
Joining the Dots: Criminal Justice, Treatment 
and Harm Reduction: 1st Conference of the 
Connections Project
Venue: Krakow, Poland 
Organised by / Contact: European Institute of 
Social Services 
www.connectionsproject.eu/conference2009 
Information: This fi rst European conference 
will facilitate the introduction and promotion 
of more effective, comprehensive, evidence-
based policies and services to respond to 
drugs and infections in prison and within the 
wider context of the criminal justice system. 
The conference will build on the learning 
and networks developed through previous 
conferences of ENDIPP (the European Network 
on Drugs and Infections in Prison). It will 
examine how responses to drugs and infections 
can incorporate treatment and harm reduction 
across the criminal justice system. The event 
is organised together with the Conference 
Consortium and will combine plenary sessions, 
presentations and workshops and provide space 
for networking and sharing of experiences 
among European and international experts and 
practitioners in the fi eld.
Improving people’s health through research and information
drugnet 
IRELAND
